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ABSTRACT

MASS SPECTROMETRY APPLIED TO PROBLEMS IN LIPID BIOCHEMISTRY:
MICROCHIP BASED APPROACH FOR LIPIDOMICS PROFILING AND ANALYSIS
OF LIPID METABOLITES BY LC-MS/MS

By
Tao Sun
May 2012

Dissertation supervised by Jana Patton-Vogt, Ph.D.
Lipidomics and metabolomics are powerful tools for the examination of cellular
metabolism and physiology. Methods for lipid analysis need to be developed that begin
with small samples and do not overly dilute or disperse the sample in the separation
process. Microchips provide a platform for interfacing lysis of small cell populations
with on-chip solid phase extraction for isolating lipid samples to generate high quality
mass spectra from very small samples. Chapter 1 of this dissertation presents a novel
method for small scale lipidomics of bacterial cells by microchip based extraction
coupled with untargeted profiling of glycerophospholipids using nanoelectrospray
ionization mass spectrometry. Chapter 2 and 3 focus on the development of LC-MS/MS
methods to study biological pathways. In Chapter 2, I describe a method for analysis of
the phospholipids metabolite, GroPIns, in the medium of the pathogenic yeast Candida
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albicans. This method was applied to aid in the characterization of the GroPIns transport
protein, Git1, in C. albicans. Chapter 3 extends the studies of part two and describes an
efficient method based on HILIC-MS/MS for the separation and quantification of five
lipid-related extracellular metabolites in yeast Saccharomyces cerevisiae. This newly
developed methodology was successfully applied to determine the extracellualr levels of
glycerophosphoinositol, glycerophosphocholine, glycerol 3-phosphate, inositol and
choline in wild type and mutant strains.
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Chapter 1

Novel Analytical Technique to Study
Glycerophospholipids on a Microchip1

1

The work described in this Chapter is reprinted with permission from:

Sun, T.; Pawlowski, S.; Johnson, M. E. Highly efficient microscale purification of
glycerophospholipids by microfluidic cell lysis and lipid extraction for lipidomics
profiling, Analytical Chemistry, 2011, 83 (17), 6628-6634. Copyright (2011) American
Chemical Society.

1

1.1 Abstract

In this chapter, a microfluidic chip-mass spectrometry based method for nontargeted profiling of lipids from cell extracts is described. The technique can in principle
be used for lipid analysis in micro scale when working with small populations of cells (1
to about 1000). This is very often the case in biological applications in sample cleanup
and separation for lipid identification. The developed system packed with fresh silica
beads allows for on-chip cell lysis and lipid extraction without any loss during the
process, which is capable of being reused for the first four runs. The acceptable
extraction efficiency is obtained by integrating silica beads as the packing material with
methanol as the eluent. This work demonstrates the potential of incorporating microchipbased lipid extraction into cellular lipidomics research. The application of the
methodology was extended to the discovery profiling of lipid from Sulfurospirillum
barnesii strain SES-3 cells, which revealed the presence of 173 identified phospholipid
species based on the high-resolution tandem mass spectrometry data. The work has been
published in the Analytical Chemistry journal (Sun et al., 2011). The novelty of the
microfluidic approach can be generally applied to any systems of interest and is the
platform employed in microscale lipid studies in future research of our lab, it is thus
imperative to describe its development in detail.

2

1.2 Introduction

Lipids are a diverse group of biomolecules that are known to exist as thousands of
distinct covalent entities, each with its unique structural and physical characteristics.
They are essential cellular constituents that have multiple distinct roles in cellular
functions. It is commonly accepted that lipids are bioorganic hydrocarbon based
molecules that are soluble in nonpolar solvents but are almost insoluble in water due to
their makeup consisting mostly of carbon. Lipids have various biochemical duties
including energy storage (fats and sterols such as cholesterol), cell makeup such as lipid
bilayers and micelles (phospholipids), and some are essential hormones (steroids and
eicosanoids). They play an important role as constituents of cellular membranes for
separating cells from the external environment, compartmentalizing cells, and proving a
special milieu for various biochemical processes. The contribution of lipids to the
composition of membrane in different organisms and cells varies depending upon the
type and function of the structures [1-3].
Phospholipids are present in all organisms, from archaebacteria, to plants, to
humans [4]. These hydrophobic molecules are the building blocks for cellular
membranes (lipid bilayer), yet perform a diverse number of other functions, from
compartmentalization of cytoplasm to the housing of proteins involved in cell signaling,
intercellular adhesion, and cytoskeletal support [5], as well as serving as a precursor pool
for biologically active lipid mediators [6]. The two common structural classes of
phospholipids found in eukaryotic cells are sphingomyelins and glycerophospholipids.
Abundant glycophospholipids also are constituents of prokaryotic cells [7]. The general
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structure of glycerophospholipid (Figure 1-1) is that of a three-carbon sugar molecule
with a fatty acyl or alkyl group at the sn-1, fatty-acyl groups at the sn-2 positions, and a
characteristic phosphate ester group at the sn-3 position of glycerol. The major distinct
classes of glycerophospholipids are subdivided based on the nature of the polar “head
group” at the sn-3 position of the glycerol backbone in eukaryotes and eubacteria or the
sn-1 position in the case of archaebacteria [8].

Figure 1-1 Structural relationships of glycerophospholipid classes. Different classes have either
ester (acyl), alkyl ether (alkyl) or vinyl ether (alk-10-enyl) substituents at sn-1, fatty-acyl
substituents at sn-2, and a polar head group at the sn-3 position of glycerol. The abbreviations
used throughout this review are indicated for each polar head group.

Approximately 60% of the lipid mass of eukaryotic cell membrane are composed
of phospholipids [9]. Minute changes in phospholipids can lead to major consequences
on cell membrane function and viability. Fatty acids that are esterified at the sn-1 and sn2 positions of the glycerol backbone can very in length from 14 to 22 carbons and can
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have from 0 to 6 double bonds [10]. The nomenclature of phospholipid is due to the
polar head group: phosphatidylcholine (PC), phosphatidylethanolamine (PE),
phosphatidylinositol (PI), phosphatidylglycerol (PG), phosphatidylserine (PS) and
phosphotidic acid (PA) as shown in Table 1-1. The cell membrane has an asymmetrical
distribution of phospholipids. PE and PS are the major phospholipids found in the inner
cytosolic membrane while the outer leaflet is primarily composed of PC [11]. Most cell
membranes are composed of phosphatidyl linkages [9]. The sn-2 bond for the fatty acid
is always an ester bond and unsaturated fatty acids are more possible. The format x:y
represents the number of carbons is x and the number of double bonds is y for the
common notation of a molecular species. Over 1000 individual molecular species of
phospholipids can be devised in theory.

Name

Head group

Phosphatidylcholine

Choline

Phosphatidylinositol

Inositol

Phosphatidylglycerol

Glycerol

5

Structure

phosphatidylserine

Serine

Phosphatidylethanolamine

Ethanolamine

Table 1-1 Various polar head groups link to the phosphate group at the sn-3 poition.

The quantitative study of lipids, or “lipidomics”, is a burgeoning field in
bioanalytical chemistry [12-14]. Low detection limits are important to lipid studies
because some lipids occur in trace (picomolar (10-12) to nanomolar (10-9)) and even
ultratrace (femtomolar (10-15) and below) concentrations in samples [15-17]. Two
branches of chemical analysis play an important role in “omics”: separation science and
mass spectrometry. In lipidomics, distinct subclasses of lipids, obtained by liquid
extraction from a cell or tissue mass, are isolated by solid phase extraction, liquid
chromatography, or thin-layer chromatography and then analyzed by a further dimension
(or two) of liquid chromatography and two or more dimensions of mass spectrometry [9,
18]. One difficulty in profiling the chemical population of a small sample is that the
lipidome exists over a wide range of concentrations. The most critical issue in analyzing
such samples is that the less abundant species can easily get lost if the sample is wasted
during inefficient sample processing steps. In addition, a relatively large amount of
sample is required in some commonly used techniques such as thin layer chromatography
(TLC) [19, 20]. One way to overcome these issues is to reduce sample transfer steps and
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dead volume by applying a microchip platform for all or part of the sample preparation
scheme.
Micro total analysis system (μTAS) also called “lab-on-a-chip” is a novel
technique of which the applications are addressing fundamental biological questions,
creating new biomedical reagents, and developing innovative cell and biochemical assays
that shrink an entire experimental device to the scale of a microscope slide [21, 22]. The
system is able to offer improved performance, smaller amounts of sample consumption,
lower cost, and higher throughput. Additionally, it is essential for understanding
physiologic and pathologic processes at the cellular level by investigating the
intracellular contents of single cells. Chemical analysis and chemical synthesis are the
two main fields of μTAS, which are of significant interest to biological, medical, and
pharmaceutical societies. Many of these concepts were brought to fruition by the
application of basic photolithography to creation of channels in glass microchips [23-27].
During the past 2 decades, the field of microfluidics has grown to include not only chips
that separate compounds by capillary electrophoresis (CE) [28] but also chips that create
gradients, chips that integrate cell lysis with DNA capture, and even chips that allow for
nanoscale reactions. Highly assembled microchips have been developed to capture
multiple single cells, lyse them, perform chemical reactions and detect chemical species
in individual cells. Cell lysis is generally performed by either chemical or physical
methods to rupture the cell phospholipd membrane with the goal of extracting
intracellular contents. Different cell lysis methods have been developed on microfluidic
platforms including chemical lysis, mechanical lysis, electrical lysis, thermal lysis, and
other lysis methods.

7

When on a chip, the use of reduced volumes of solvent and electrophoretic
separation can eliminate the need for the centrifugation and resuspension. This
multidisciplinary field is comprised of physicists, chemists, engineers, and biologists all
working to get the most out of these devices. The ability of microfluidic devices to
efficiently handle complex samples and subsequently perform the required analytical
operations on the same chip will be essential to the final successful applications of
microfluidic systems. The integration of sample pretreatment within microfluidic devices
has recently become an important area of emphasis in the field of μTAS. However, there
are very few reports in the area of microfluidic chips associated with lipid extraction for
lipidomics analysis.
The standard approach to lipid class isolation is based on either thin-layer
chromatography (TLC) or solid-phase extraction (SPE), both of which are applied after a
modified Bligh-Dyer extraction [29]. The biggest problem with TLC or SPE is that
sample sizes are generally large (grams of tissue, >107 cells). In this chapter, a novel
method for a microchip-based solid phase extraction for purification and enrichment of
microscale glycerophospholipids is described. Specifically, intact bacterial cells loaded
onto a chip were immediately lysed to release their lipid content. The released lipids
were captured on a stationary phase and eluted with a suitable elution solvent. The
nonpolar tails of the membrane lipids were captured by the nonpolar C18 beads of the
column, while the polar head groups of the lipids were captured by the polar silica beads.
On-chip lipid extraction efficiency and reproducibility were evaluated by comparison to
the modified Bligh-Dyer method [29]. The purified lipids were reconstituted and injected
directly into a quadrupole-time-of-flight mass spectrometer (Q-TOF MS) for analyzing
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lipids content in the membrane. The characterization of phospholipids from lipid extracts
by electrospray ionization (ESI) MS is based on the ability of each lipid class to acquire
positive or negative charges when in solution under the ionization source high energy.
Lipids that do not possess inherently ionizable moieties can also be ionized under the
conditions of ESI. As long as there is sufficient dipole potential for interaction with
counter ions, these species can be analyzed. As a result under suitable conditions of
sample preparation, all molecular species that exist among cellular lipid classes can be
detected in a single run of an on-chip lipid extraction. A single molecular ion with a
mass-to-charge ratio (m/z) characteristic for the monoisotopic molecular weight is
present for each molecular species. The MS data were analyzed using both the METLIN
Personal Metabolite database [30] and the LIPID MAPS (www.lipidmaps.org) database
by integrating with MassHunter Qualitative Analysis software for lipidomics discovery
profiling. Several specific lipid databases and software packages have been developed
(Table 1-2) over last ten years. The approach of the LIPID MAPS has attempted to
establish a standard platform for lipid nomenclature [14, 31]. METLIN Personal
Metabolite database is designed specifically for metabolomics, which may also be
employed for lipid identification and quantification. With this method, we were able to
identify over 170 phospholipid species from bacterial cell extracts.

Name

Comments

Web site

LIPID MAPS

Open-access, Web search engine

http://www.lipidmaps.org

Lipid Bank

Open-access, Web search engine

http://lipidbank.jp

METLIN

Open-access, Web search engine

http://metlin.scripps.edu
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for metabolomics studies
AMDMS-SL

A freeware package designed for

http://www.shotgunlipidomics.com

shotgun lipidomics
MZmine 2

A freeware package designed for

http://mamine.sourceforge.net

metabolomics studies
LipidView

Commercial software that

http://www.mdssciex.com

performs complete data analysis
LIMSA

A freeware package that can be

http://www.helsinki.fi

downloaded from the Web
LipidX

A subset of the systems biology

http://www.systemsm.ch

freeware Systems X
LipidQA

A freeware package that can be

http://msr.dom.wustl.edu

downloaded from the Web
Table 1-2 Databases and software packages for lipid analysis.

1.3 Experimental
1.3.1 Reagents

34:2 phosphatidylcholine (PC) and 34:1 phosphatidylinositol (PI) were purchased
from Sigma-Aldrich (St. Louis, MO). All solvents were HPLC grade from Fisher
Scientific (Pittsburgh, PA) and were filtered through a 0.22 μm nylon membrane filter
(Whatman). Tri(hydroxymethyl) aminomethane (Tris) was from Fisher Scientific.
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Omnipur egg white lysozyme was purchased from EMD Chemicals (Gibbstown, NJ). A
buffer solution for system washing was adjusted to 7.5 with 20 mM Tris

1.3.2 Microchip Fabrication

Microchips were fabricated roughly according to standard photolithographic
technique [32]. Schott Borofloat glass plates (1.5mm thick, Telic Company, Santa
Monica, CA) precoated with chrome and AZ 1518 negative photoresist (5300 Å thick)
were used to fabricate microchips by standard photolithographic techniques [33]. The
primary design for the microchips used in this study is a T-shape channel (Figure 1-2A).
The image for the desired chip features were designed in Adobe Illustrator (CS2, Adobe,
Inc.) and were printed on a high-resolution inkjet printer (Canon Pixma Pro900, 4800 ×
2400 dpi). The chip features were clear on the photomask. Clear glass covered by
photomask was placed in a laminar flow hood, Arilean 600 PCR Workstation (Raleigh,
NC) with a red light to prevent damaging the mask, and they were exposed under UV
radiation , Spectroline SB-100PC of 60 MHz, 1.05 Amp, and long wavelength of 365nm
(Westbury, NY), for transferring the pattern to the photoresist for 30 second.
The exposed photomask blank was then placed in 15 mL of AZ 300 MIF
developer (AZ electronics materials USA Corp., Somerville, NJ). The solution was
swirled over the top of the photomask blank for 30 seconds to solubilize the exposed
region of the photoresist. The developed blank was then rinsed with deionized water for
40 seconds to remove the developer, after which it was placed in 25 mL of CR-9

11

Chromium Photomask Etchant (Cyantek Corp, Freemont, CA) and was swirled over the
top of the photomask blank for 1-2 min until the chrome was removed. The mask was
then rinsed again for 40 seconds with deionized water to remove any remaining chrome
in the channels. Before the photomask blank was etched, the initial width of the channel
was measured using a microscope with an optical scale, and determined to be 100 µm. In
order to produce a channel with a width of 300 μm and a depth of 200 μm, both top and
bottom masks had line features that were 100 μm wide. A channel with a total depth of
200 μm was made by etching both the top and bottom of glass pieces 100 μm deep, and
each channel was etched laterally by 100 μm, giving a channel that was 300 μm wide at
its axis (Figure 1-2B). The glass was etched using a 14:20:66 (v/v/v) HNO3/HF/H2O
solution with the total etching time of 28 min. The etching of the weirs in Figure 1-2C
was observed under a light microscope and a zoom stereomicroscope (Leica Wild,
Wetzlar, Germany), and the plate was rinsed with deionized water. The remaining
chrome and photoresist were removed and the glasses were washed thoroughly.
Using an Accu Press drill (DynaArt Design, Lancaster, CA), and a diamond
tipped drill bit (0.75mm), fluidic access holes were drilled in the wells at the end of each
channel for capillary connections. Water was poured onto the access holes while drilling
to keep the glass from cracking. More importantly, the drill bits would vaporize from
heat if not cooled with water. The chip glass was vigorously washed with deionized
water. Three pieces of the microchip were cut from the photomask blank using a
glasscutter, and then rinsed with deionized water using a water spigot. The drilled chips
were placed in 15 mL of RS-120 Resist Stripper (Cyantek Corp., Fremont, CA) at 50 oC
for 5 minutes to remove the remaining photoresist. The solution was swirled until all of
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the remaining resist had dissolved and then rinsed with deionized water for 2 minutes.
The glass chips were then placed into CR-9 chrome etchant and swirled until the
remaining chrome was dissolved. After that, they were rinsed with deionized water and
then placed in 15 mL of nanostrip (Cyantek Corp., Fremont, CA) to remove any
remaining organic solvents on the chips. The chips were then swirled in nanostrip for 3
minutes and then rinsed again for 40 seconds in deionized water. The water spigot was
used to trace the channels to remove any excess debris. The plates were subsequently
placed in RCA solution, made up of 75.0 mL deionized water, 15.0 mL NH 4OH mixed
on a hot plate at 60°C. 15.0 mL of H2O2 was added to the RCA solution, after which the
chips were put into this solution, and swirled for 30 minutes. The chips were removed
from the solution and each piece was rinsed and cleaned thoroughly for 5 minutes with
deionized water using the water spigot to ensure proper bonding.
The top and bottom chip were subsequently brought into contact while still wet
and were held together by capillary action. Finally, the assembly was placed in a furnace
(Lindberg/Blue Moldatherm, Thermo Fisher Scientific Inc., Asheville, NC). The furnace
temperature was raised at a rate of 10 °C/min to 80 °C and was held for 30 min, after
which it was ramped at the same rate to 610 °C and held for 8 h. The temperature was
then decreased to room temperature at a rate of 10 °C /min. The chips were examined
with the stereoscope to ensure that they were properly aligned and no shift occurred
during the bonding process [34, 35]. The weir structures were fabricated by leaving a
gap in the channels in the photomask that was etched only part way through. The
isotropic etching process created a very small open portion at the top with a sloping
bottom in the channel. When bonded to a top channel, the net result was a channel with a
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double trapezoidal structure, 120 μm wide at top and bottom, 300 μm wide in the middle,
with an elliptical weir that was about 10-15 μm wide at the widest (top to bottom) (Figure
1-2).
The microchip was firstly conditioned by sequentially pumping about 100 μL
each of 1 M sodium hydroxide, deionized water, and methanol before packing. The
packing material used as the stationary phase was either spherical silica gel (100 Å, 20
μm, Sorbent Technologies, Inc., Norcross, GA) or C18 silica gel (100 Å, Luna 15 μm,
Phenomenex, Torrance, CA). A slurry of packing material made with methanol was
introduced to the reservoir on the side arm of the chip by applying a mild vacuum
through the other two reservoirs using pipet tips attached to a vacuum pump (Figure 12D). The packing was done under a zoom stereomicroscope. Once the chips were
packed, the lower bead-hole of the T-shape was sealed with epoxy and left to dry
overnight before use (Figure 1-2E). Adhesives were placed around the other two wells,
to which the nanoports were attached. The nanoport of one well was connected with
PEEK tubing of the injection pump, by which water was passed through the channel to
test the flow of each chip.
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Figure 1-2 Design of the microfluidic device. (A) The schematics of the microchip for cell lysis
and lipid extraction. (B) Cross-sectional diagram of the SPE channel. (C, D) Images of the weir
structure and the packed column. (E) Silica beads are packed in the microchannel through the
bead-hole on the side-arm of the chip using a mild vacuum until the channel is fully packed.
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1.3.3 Online Extraction System

The home-built microfluidic chip apparatus for solid phase extraction consisted of
a Harvard Apparatus model 11 syringe pump (Harvard Apparatus, Holliston, MA) and a
250 μL Hamilton gastight syringe (Hamilton, Las Vegas, NV). Reagents were injected
using an HPLC type injection valve (Rheodyne 7725, Rohnert Park, MA) with a 40 μL
injection loop. The injection port was connected to the chip with polyether ether ketone
(PEEK) tubing (1/16 in. o.d. × 0.010 in. i.d., Upchurch, Oak Harbor, WA) and custom
pressure holders or Upchurch Nanoports (Figure 1-3). To flush out any unreacted species
and prepare the solid phase for extraction, freshly filled microchips were conditioned
with 20 mM Tris buffer (pH 7.5) for 30 min at 10 μL/min. The solid phase was
reconditioned under the same conditions for 10 min before each extraction step. The
primary extraction protocol consisted of three pressure driven wash steps, each performed
at a flow rate of 10 μL/min. First, the injection valve was switched to “load” and 20 μL
of the lysing agent was loaded onto the chip. A sample of 10 μL of cells was injected
immediately thereafter, followed by loading of another 20 μL of lysing agent onto the
bed. The valve was then switched back to “inject”, and 100 μL of the wash solution (20
mM Tris buffer) was flowed through the chip to eliminate proteins and other potential
nonlipid materials. Finally, the purified lipids were eluted in selected eluent (methanol,
isopropanol, or acetonitrile on a silica bed; chloroform/methanol, 2:1 (v/v) or
tetrahydrofuran/methanol, 1:1 (v/v) on a C18 bed) and were collected in sample vials for
subsequent mass spectrometry analysis. To eliminate carry-over, the solid phase was
flushed with methanol for 30 min at a rate of 10 μL/min between each run.
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Figure 1-3 The microdevice setup used for extraction of lipid from bacterial cells. The flow system
consists of a syringe pump, which is connected to an HPLC type injection valve for loading the
lysing agent and Tris buffer to the microchip.

1.3.4 Cell Staining and Lysis

Sulfurospirillum barnesii strain SES-3 cells were kindly provided by Dr. P. Basu,
Duquesne University. S. barnesii is a readily available arsenate respiring bacterium with
a simple lipidome [36, 37]. The cells were treated with a cell-labeling dye that stains
intact cells but displays a large decrease in fluorescence when cells are completely lysed
[38]. The dye DiO (Invitrogen Molecular Probes, Inc., Carlsbad, CA) was prepared
according to the manufacturer’s instructions, and the prepared stock solution was stored
at -20 °C. To stain the cells, a 0.5 mL portion of live cells was placed in a
microcentrifuge tube. A volume of 1 μL of 1:100 diluted DiO stock solution was added
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to the live cells, and the contents were vortexed for 1 min. The final concentration of the
dye was 0.6 M.
A solution of washed S. barnesii strain SES-3 cells was prepared as follows.
First, 0.5 mL of cells was placed in a 37 °C water bath for 8 min. After heating, the tube
was centrifuged for 5 min at 6 900g, during which a pellet was formed and the
supernatant was subsequently removed. The cells were then washed in 0.5 mL of 20 mM
Tris buffer, and a pipet was used to break up the cell pellet. The tube was vortexed for 1
min, then centrifuged for another 5 min at 6 900g. The supernatant was removed and
discarded after centrifugation. The pellet was finally resuspended in 0.5 mL of 0.15 M
Tris buffer.
Lysing agent was prepared by adding 20 mg of Omnipur egg white lysozyme
(EMD Chemicals, Gibbstown, NJ) to 6 mL of 20 mM Tris HCl buffer with a pH of 7.5.
To lyse the cells, the lysing agent was loaded onto the microchip by syringe flow using a
Harvard PHD 2000 syringe pump at a flow rate of 10 μL/min for 24 s followed by
loading of the stained cells for 12 s. The lysing agent was then flowed over the bed at the
same flow rate for another 24 s. The loading time was calculated to take into account any
dead volume of the column and tubing.
In the loading and lysis steps, cells were imaged fluorescently at the inlet
reservoir of the microchip using a Nikon Eclipse E-600 microscope with a 100 W
mercury lamp. A FITC-HYQ filter set (excitation bandpass filter 480 (20 nm, dichroic
reflector 505 nm cut-on, and emission bandpass filter 535 (25 nm) was applied for the
imaging. The images were recorded using a RT-slider camera and a QED camera
standalone program. The contrast of the images was enhanced using Adobe Photoshop
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CS4.

1.3.5 Modified Bligh-Dyer Method and Thin Layer Chromatography

In our protocol, 0.2 mL of cultured cells were mixed with 0.75 mL of
chloroform/methanol, 1:2 (v/v) and vortexed for 1 min. A volume of 0.25 mL of
chloroform and 0.25 mL of deionized water containing 1% acetic acid were added into
the mixture and vortexed for another 1min. The solution was subsequently centrifuged at
1300 rpm for 5 min. The lower phase was collected with a Pasteur pipet and then
evaporated followed by reconstitution in 0.5 mL of methanol with 10 mM NH4OH.
Samples were introduced into the electrospray ionization-quadrupole (ESI-Q) mass
spectrometer for lipid profiling, and the profile was compared to that obtained using the
microchip method.
A TLC method was used to facilitate developing a separation of the main
phospholipids classes present in the cell membranes. TLC was performed on silica gel
plates, which were pretreated (full length) in a Camag horizontal developing chamber to
remove impurities by methanol: ethyl acetate (6:4). The plates were activated for 10
minutes at 130oC. Phospholipids, extracted according to Bligh and Dyer, were loaded to
TLC plate at 10 mm from the edge using 10 µl capillary pipette 5 times. 500 ng/µl of
each standard phospholipid, phosphatidylethanolamine (PE), phosphatidylinositol (PI),
sphingomyelin (SM), and their mixture, were also applied on TLC plate.
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The plate was developed in a developing chamber containing dichloromethane:
ethyl acetate: acetone (80:16:4) for 70 mm to separate cholesterol, free fatty acid, and
triglycerides from phospholipids to prevent overloading of the silica particles at the start
position. The plate was dried under an air stream (40 oC) for 10 minutes. The
phospholipids were subsequently separated by chloroform: ethyl acetate: acetone:
isopropanol: ethanol: water: acetic acid (30:6:6:6:16:28:6:2) elution for 55 mm. The
plate was dried for 5 minutes at 130oC and placed into the iodine staining chamber face
down at a 45o angle, with the top of the plate on the bottom of the chamber. After 5
minutes, the plate was removed and immediately placed face down on the bed of the
scanner to ensure minimal evaporation of iodine. The images were cropped and saved
in compressed TIFF format for further analysis [39-42].

1.3.6 Mass Spectrometry Conditions

The characterization of phospholipids from lipid extract by ESI-MS is based on
the ability of each lipid class to acquire positive or negative charges when in solution
under the ionization source high energy. Lipids that do not possess inherently ionizable
moieties can also be ionized under the conditions of ESI-MS, and as long as there is
sufficient dipole potential for interaction with counter ions, these species can be analyzed.
Thus under suitable conditions of sample preparation, all molecular species that exist
among cellular lipid classes can be detected in a single run of an on-chip lipid extraction.
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A single molecular ion with a mass-to-charge ratio (m/z) characteristic for the
monoisotopic molecular weight is present for each molecular species.
In order to obtain higher resolution in spectrum, an Agilent 6520 nano
electrospray ionization quadrupole time-of-flight (nanoESI-Q-TOF) mass spectrometer
was used for lipid extracts profiling. Aliquots (20 μL) from loading, washing, and elution
steps were collected during the extraction. The lipid extracts were dried by N 2 and
resuspended in HPLC-grade methanol with 10 mM NH4OH. Samples were introduced
by direct infusion using a Harvard PHD 2000 syringe pump at a flow rate of 70 μL/h.
MS only data was acquired in both positive and negative ion modes. The following
settings were maintained throughout the analysis: drying gas flow of 10 L/min, drying
gas temperature of 350 °C, nebulizer pressure of 45 psi, data range of m/z 200-1000,
acquisition rate of 1000 ms/spectrum, fragmentor voltage of 150 V, skimmer voltage of
60 V, octopole rf voltage of 250 V, and capillary voltage of 3.5 kV. Typically, a 1 min
period of signal averaging in the profile mode was employed for each spectrum.

1.3.7 Data Analysis

METLIN Personal Metabolite database and LIPID MAPS database were applied
for the identification of phospholipids species present in cell extracts. This application
enabled us to enter the m/z value of an unknown lipid ion or a batch of lipids and predict
the most likely molecular species, based on internally generated lists of side-chains and
headgroups of phospholipids. LIPID MAPS database was set as: intensity threshold:
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100; mass tolerance: +/- 0.01 amu; ion mode: [M+H] +; sort by: molecular formula. Six
major phospholipid classes were detected in positive and negative ion mode:
phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylglycerols (PG),
phosphatidylcholines (PC), phosphatidylethanolamine (PE), and phosphatidic acid (PA).
Additionally, the lyso variants for all of the above mentioned phospholipids (LPI, LPS,
LPG, LPC, LPE, and LPA) and phosphatidylinositol monophosphate (PIp) were also
detected during the process.

1.4 Results and Discussion
1.4.1 Overview

The goal of this work was to create a simple microdevice for effective cell lysis
followed by lipid capture, cleanup, and recovery. A few preconditions must be met in
order to ensure a seamless coupling of solid phase extraction and a microfluidic platform.
First, the lysing agent must effectively lyse intact cells in the volume present in the
microchannel. Second, the released lipids must bind to the extraction bed successfully.
Finally, the retained lipids must be eluted from the solid phase with high extraction
efficiency and consistent reproducibility (recovery rate). A typical MS-based lipidomic
workflow is illustrated in Figure 1-4, which shows that the initial step in data analysis is
lipid identification.
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Figure 1-4 Workflow of lipidomics analysis in systems-level scale.

1.4.2 Evaluation of Lysing Agent

In order to consistently extract lipids from bacteria cells with high efficiency, it is
necessary to lyse the cells completely. Figure 1-5A depicts the bacteria cells after the
initiation of flow of the lysing agent into the inlet port of a complete microfluidic device.
The fluorescence signal decreased after 1 min of flow and was undetectable after 3 min
(Figure 1-5B), which confirms the sufficient lysis of the cells. Thus, these lysing
conditions were applied in the subsequent experiments.
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Figure 1-5 Fluorescence images of on-chip cell lysis under microscopy at 20× magnification. (A)
Image taken when DIO labeled cells were flowed into the inlet irradiated with 480-560 nm light.
(B) Image taken after flow of the lysing agent over 3 minutes.

1.4.3 Effect of Lipid Extraction

As the lysing agent for cell lysis had been chosen, it was necessary to make
sure that released lipids successfully adsorbed to silica surfaces. Several purification
goals must be achieved to recover phospholipids from cells and adsorb them to the silica
phase in a single step. To make the purification protocol as simple and effective as
possible, cell lysis and lipid binding to silica surfaces were accomplished using one single
loading buffer. Several factors are taken into account when choosing the loading buffer.
Solutions of high ionic strength facilitate the adsorption of phospholipids on the
stationary phase as a result of a variety of interactions. At higher ionic strength, the
negative potential of silica surfaces is reduced, thereby decreasing the electrostatic
repulsion between the negatively charged phospholipid molecules and the bead surface.
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However, high concentrations of salt reduce the water activity due to the formation of
hydrated ions, which facilitates the dehydration of phospholipids and silica surfaces and
drives the lipid to the extraction bed [43]. The electrostatic repulsion can be further
reduced if the phospholipid is dissolved in a loading buffer below the pKa of the silica
(pKa ≈ 8), due to the fact that increasing protonation of the surface silanol groups reduces
the surface charge [44-46]. In addition, extremely acidic loading buffer conditions could
affect the solubility of lipids and may induce precipitation, which could ultimately lead to
a failure of the microfluidic device. Consequently, a buffer of 20 mM Tris HCl with pH
of 7.5 was chosen for phospholipid adsorption to silica surfaces.
According to previous research on the physicochemical properties of silica
materials for lipid extraction, surface properties play a critical role in the extraction of
hundreds or even fewer cells [47, 48]. Size and shape of the particles, diameter and
volume of the pores, and the packing and resin porosity are of major concerns to the
overall effectiveness of phospholipid binding. In this work, two types of silica resins,
silica beads (100 Å, 20 μm) and C18 beads (100 Å, Luna 15 μm), were selected as the
packing material to adsorb the phospholipids. The microporous structure prevents the
macromolecular proteins from going through the beads while keeping small analytes
including polar lipids from entering and being retained.
The performance of lipid extraction on the microchip was evaluated by extraction
efficiency and reproducibility during the purification process. The recovery of
phospholipids from the device was accomplished using various elution solvents with high
ionic strength. Methanol, chloroform and acetonitrile were used on silica phase while 2:1
chloroform/methanol and 1:1 tetrahydrofuran/ methanol were used on C18 phase. An
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electrospray ionization-quadrupole (ESI-Q) mass spectrometer (Waters ZMD MS) was
utilized in the study of lipid species profiling. The lipid extracts were eluted by methanol
(Figure 1-6), acetonitrile (Figure 1-7) and isopropanol (Figure 1-8) on microchip packed
with silica beads.

Figure 1-6 ESI-Q MS profile of lipid extracts eluted by methanol from silica packing microchip.
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Figure 1-7 ESI-Q MS profile of lipid extracts eluted by acetonitrile from silica packing microchip.

Figure 1-8 ESI-Q MS profile of lipid extracts eluted by isopropanol from silica packing microchip.

27

Lipids were also extracted by 2:1 chloroform/methanol (Figure 1-9) or 1:1
tetrahydrofuran/ methanol (Figure 1-10) on the microchip packed with C18 beeds. A
shift in overall mass in going from C18 to silica was observed, which indicates different
extraction efficiency and tendency by using different eluents.

Figure 1-9 ESI-Q MS profile of lipid extracts eluted by 2:1 chloroform/methanol from C18 packing
microchip.
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Figure 1-10 ESI-Q MS profile of lipid extracts eluted by 1:1 tetrahydrofuran/methanol from C18
packing microchip.

In contrast to loading buffer, the eluent exhibited a slightly higher back-pressure
due to its high viscosity, which caused a drop in flow rate to 8 μL/min. In order to
evaluate the lipid extraction efficiency, the numbers of identified phospholipid species
extracted from the microchip by different eluents were compared with that obtained by
the modified Bligh-Dyer method (Figure 1-11)
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Figure 1-11 ESI-Q MS profile of total lipid extracts by Bligh and Dyer extraction methed.

The overall extraction efficiencies of the silica chip with different eluents were
83.3% (methanol), 49.3% (isopropanol), and 29% (acetonitrile), respectively (Figure 112). When the phospholipids were eluted from the C18 chip by chloroform/methanol
(2:1, v/v) or tetrahydrofuran/methanol (1:1, v/v), the on-chip extraction efficiencies were
71.7% and 61.8% compared to that obtained using the modified Bligh-Dyer method
(Table A-1 in Appendix I). Thus, silica beads were selected as the packing material with
methanol as the eluent for lipid extraction in subsequent experiments. Lipid extracts
from Bligh and Dyer were run through thin layer chromatography to identify the
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component of lipid classes. Non-phospholipids (CE, TG, FFA) were separated from
target lipids to upper plates. PI and PE were identified comparing to standards selected
(data not shown). TLC was used to prove that total lipid extraction from the cell by Bligh
and Dyer method did extract the expected phospholipids.

Figure 1-12 Comparison of on-chip extraction efficiencies of phospholipid using different eluents.
Silica (black) and C18 (gray) resins were applied as packing materials. The error bars represent
the variation of four individual experiments. Values represent mean ± S.E. of triplicate
determinations.

1.4.4 Reproducibility
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Before each extraction, the silica beads were reconditioned by flushing methanol
for 30 min, followed by another flush with 20mMTris buffer for 10min. In a
measurement where 10 μL of 34:2 phosphatidylcholine (PC) and 34:1
phosphatidylinositol (PI) (Sigma-Aldrich Chemical Co., St. Louis, MO) standard mixture
were loaded at a final concentration of 5 μM for 10 successive extractions, the average
phospholipid recovery rate for the microchip was 55.34% and 46.12%, respectively
(Figure 1-13). It is shown that the reproducibility of lipid extraction from the silica bed
decreases after the fourth run. In order to overcome this issue, new silica beads were
packed to the chip, and the lipid recovery rate went back to around 65% for 34:2 PC. In
summary, the microchip packed with fresh silica beads is capable of being reused four
times without any loss in the lipid extraction process.
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Figure 1-13 Phospholipid recovery rate on the microchip over ten successive extractions.
Standard mixtures of 5 μM 34:2 PC (black) and 34:1 PI (gray) were used. Values represent mean
± S.E. of ten successive measurements in triplicate determinations.

1.4.5 Extraction Profile

To ensure that phospholipids were eluted from cells only when the eluent was
applied, fractions were collected and analyzed for a phospholipid elution profile during
extraction and the results are shown in Figure 1-14. During this extraction step, a sample
of 10 μL cells sandwiched with 20 μL of lysing agent was loaded onto the silica bed at a
flow rate of 10 μL/min. After a wash with 20 mM Tris HCl buffer (100 μL, pH 7.5),
during which any nonlipid materials were removed, the lipids were eluted in methanol. A
total of 18 fractions of the eluate (20 μL each) were collected at the outlet of the device
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during each step of the extraction (cells loading/lysing, nonlipid materials washing, and
lipids elution). The phospholipid 34:1 PI was chosen for lipid quantification during the
extraction process by the nanoESI Q-TOF mass spectrometer. As shown in Figure 1-14,
the major elution of 34:1 PI occurred in the first 80 μL of the elution phase, with
negligible concentrations of lipid detected in other steps. This result indicates that there
was no significant loss of lipid during the loading and washing steps, and most of the
extracted 34:1 PI was eluted from the first several tens of microliters. These results are
consistent with the fact that 34:1 PI was eluted reproducibly in the first 80 μL of the
elution phase, which suggests that the lysing agent/loading buffer did not interfere with
binding of the lipid to the silica bed or impact lipid recovery negatively.

Figure 1-14 Extraction profile of 34:1 PI from the silica chip eluted by methanol. Fractions (20 µL
in volume) were manually collected during loading, washing and elution steps.
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1.4.6 Data Analysis

In order to identify the molecular species of phospholipids from S. barnesii cells,
the nanoESI-Q-TOF MS/ MS was applied along with “untargeted” (discovery profiling)
approaches for lipidomics research. The data analysis workflow consists of interrogation
of lipid extracts data files from MS by a METLIN Personal Metabolite database and
LIPID MAPS database. LIPID MAPS provides a platform that has the versatility to
quantify known individual lipid molecular species and search for novel lipids affecting
biological systems. With the list of possible identities significantly narrowed,
phospholipid species were identified using a custom subset of the METLIN Database
relevant to lipid metabolites in the mode of accurate-mass information searching. Sample
data files were subsequently imported in MassHunter Qualitative Analysis software
(Analyst QS) by loading the lipid database that contains the empirical formula of each
lipid species. The data files were queried by each formula using a “Find by Formula”
function, which finds and extracts all the coeluting isotopes, salt adducts, and dimers that
belong to each empirical formula.
Six major classes of phospholipid and their lyso variants were identified with this
method. Within these classes, each of the target mass identified in the profiling processes
was searched against the METLIN database over a 10 ppm mass window. A mass error
window of 5 ppm was set for the empirical formula calculation. Three major lipid
classes, PC, PS, and PE, are detected in positive ionization mode (+ESI) [49-52], while
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four major lipid classes, PI, PS, PG, and PA, are detected in negative ionization mode (ESI) [53-55]. Their representative diagnostic ions are illustrated in Table 1-3. In
addition, the lyso variants for all these phospholipids (LPE, LPC, LPA, LPI, LPS, and
LPG) can be detected in both modes. Finally, the results from METLIN searches were
incorporated into Excel spreadsheets for further interpretation.

Lipid Class

Diagnostic ion

Ionization mode

184

Positive

141

Positive

196

Negative

Phosphatidic acid

153

Negative

Phosphatidylinositol

241

Negative

185

Positive

87

Negative

172

Negative

Phosphatidylcholine
Phosphatidylethanolamine

Phosphatidylserine
Phosphatidylglycerol

Table 1-3 Diagnostic ions used for identification of major lipid classes in MS/MS

A link to the LIPID MAPS database was also provided to predict possible
phospholipids species present in the cell extracts. This application allows for input of the
m/z value of an unknown lipid ion or a batch of lipids to predict the most possible
molecular species, based on internally generated lists of side-chains and head groups of
glycerophospholipids and sphingophospholipids. The parameters used were listed as
follows: intensity threshold of 1000, mass tolerance of ±0.01 amu, and ion mode of [M +
H]+ or [M - H]-.
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Low mass peaks (below m/z 350) were assigned to free fatty acid as a result of insource collision-induced fragmentation. Peaks of lyso variants for all kinds of
phospholipids were in the range of m/z 350-600. Most of the major phospholipid classes
(PE, PC, PG, PS, PA, and PI) fell in the range between m/z 600 and 1000, which
consisted of about 70% (about 380 peak envelopes) of the MS peaks (Figure 1-15A and
15B). As shown in Figure 1-15C and 15E, 34:2 PC was detected with [M + H]+ =
758.561, and a characteristic phosphocholine headgroup peak at m/z 184.073 was shown
in the MS/MS spectrum by applying 20 eV on the extracted parent ion. Relatively small
peaks of lysophosphotidylcholines ([LPC + H]+ and [LPC - H2O + H]+ ) correspond to
the loss of one fatty acyl substitute as a ketene [M - R2CH=C=O]+. In Figure 1-15D and
15F, the peak of m/z 835.585 was assigned to 34:1 PI and its parent ion was extracted for
fragmentation at 45 eV. Lysophosphotidylinositols ([LPI - H]- and [LPI - H2O - H]-),
lysophosphatidic acids ([LPA - H2O - H]-), and the characteristic headgroup fragments
including glycerophosphoinositols ([GPI - H2O - H]- and [GPI - 2H2O - H]-), fatty acid
([FA - H]-), inositolphosphate ([IP - H2O - H]- and [IP - 2H2O - H]-), and
glycerophosphate ([GP - H2O - H]-) were observed for the specific PIs identification.
Fragmentation of these phospholipid species in both ionization modes yielded a wealth of
structural information. In each case, the lipid identification process was aided by
headgroup fragmentation, lyso-lipid formation, and fatty acid fragments. With the use of
the LIPID MAPS mass prediction tool, many possible phospholipids species and their
structures (double bonds, carbon numbers of fatty acyl chains, and head groups) were
determined. Table A-2 in the Appendix II shows a summary of the proposed
phospholipids based on METLIN database [56] and LIPID MAPS database matches of
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the measured mass of the parent ions with their theoretical mass over complementary
approach for identification of phospholipid isomers.

Figure 1-15 Mass spectra of phospholipid extracts from S. barnesii cells eluted from silica bed of
microchip by methanol. Six major lipid classes were detected in positive (A) and negative (B)
ionization modes, e.g. 34:2 PC (C) and 34:1 PI (D) were detected and their structures were
identified with corresponding tandem mass spectra (E, F).
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Empirical formulae prediction software (Analyst QS) was used to support the
stages of data processing. To the information of the mass to charge ratios of molecular
ions provided by the MS spectrum data, the criteria for filtering the most possible ions
were as follows: possible elements C, H, P, O; adducts [M+H]-, [M+NH4]+, [M-H]-; mass
tolerance 10 ppm. Within 10 ppm in mass error window, empirical formulae of the
analytes were independently matched to the predicted values. Over 170 of identified
phospholipids and lysophospholipids with 12-44 total carbons were comprised by peaks
that matched the criteria. Some peaks had more than one possible lipid species that
matched the empirical formulae in the same error score. These peaks were identified by
the corresponding fragmentation patterns using the tandem mass spectrometry in order to
obtain detailed information of the molecular ions. With this “untargeted” lipidomics
approach, as many as 173 phospholipid species were identified from on-chip bacterial
cell extracts (See Appendix II).

1.5 Conclusions

A microscale solid phase extraction method was developed for the extraction of
glycerophospholipids from bacteria cells with integration to analysis by small scale
lipidomics. A buffer solution of 20 mM Tris HCl at pH 7.5 containing 20 mg of omnipur
egg white lysozyme was demonstrated to work effectively as a lysing agent for
Sulfurospirillum barnesii strain SES-3 cells on microfluidic devices. Among different
types of stationary phase and elution solvent for lipid capture tested, the best extraction
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was obtained by using a silica phase with methanol as the eluent with the efficiency of
83.3% (Figure 1-16). Lipids purified with the developed method were suitable for
subsequent lipidomics analysis and compared favorably with lipids extracted by a
commonly utilized Bligh-Dyer method. By incorporation of both fast and robust peak
finding algorithms and visualization software, many phospholipids were found to have
matches to the METLIN and LIPID MAPS databases. In summary, this work presents a
highly efficient method for microchip based solid phase extraction for use with
microscale lipidomics.

Figure 1-16 Scheme of on-chip lipid extraction with lipidomics study by Q-TOF MS.
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Chapter 2

Analysis of Glycerophosphoinositol Uptake in Candida
albicans by Liquid Chromatography-Electrospray
Ionization Tandem Mass Spectrometry1

1

The application of the approach described in this Chapter has contributed to the
following publication:
Bishop, A. C.; Sun, T.; Johnson, M. E.; Bruno, V. M.; Patton-Vogt, J. Robust utilization
of phospholipase-generated metabolites, glycerophosphodiesters, by Candida albicans:
Role of the CaGit1 permease, Eukaryotic Cell, 2011, 10 (12), 1618-27.
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2.1 Abstract

The phosphatidylinositol (PI) metabolite, glycerolphosphoinositol (GroPIns),
which results from phospholipase B-mediated cleavage of phosphatidylinositol, exits and
enters the yeast, Saccharomyces cerevisiae. In S. cerevisiae, GroPIns is transported
across the plasma membrane via a transport protein encoded by the GIT1 gene. GroPIns
transport has not been addressed in the pathogenic yeast, Candida albicans, but the C.
albicans genome has four potential GIT1 homologs. In order to investigate and identify
the role of CaGIT1 as a GroPIns permease in C. albicans, a liquid chromatographytandem mass spectrometry based method (hydrophilic interaction liquid chromatographyMS/MS rather than reverse phase liquid chromatography-MS/MS) for quantification of
GroPIns is described. GroPIns is eluted at retention time of 13.06 ± 0.15 min with total
run time of 15 min. Quantification was performed by generation of an external
calibration curve. The developed approach was employed to monitor the levels of
GroPIns in the medium. Our results show that while a wild type C. albicans strain
transports exogenously supplied GroPIns into the cell, a strain lacking the CaGit1
permease does not.
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2.2 Introduction

Phosphatidylinositol, which accounts for up to approximately 10% of membrane
phospholipids, is widely distributed among the different cellular membranes.
Phosphatidylinositol has been reported to be degraded by at least four distinct routes [1,
2]. The fatty acid esterified at the sn-1 and the sn-2 positions of the glycerol moiety are
removed by phospholipase A1 and phospholipase A2, respectively, thus providing an
important source of fatty acid. Phospholipase B refers to an enzyme that is able to
hydrolyze the fatty acyl ester bond at both the sn-1 and sn-2 positions on glycerol. By far
the most widely studied pathway for metabolism of phosphatidylinositol involves
cleavage of the diacylglycerol-phosphate bond by phsopholipase C. Alternatively,
phosphatidylinositol appears to be hydrolyzed by cleavage of the inositol-phosphate bond
by phospholipase D to phosphatide and inositol.
The extracellular glycerophosphodiesters, such as glycerophosphoinositol
(GroPIns), are the products resulting from hydrolysis of both fatty acid chains of
phospholipids via phospholipase B-mediated deacylation. Most fungal cells including
Candida albicans contain multiple phospholipase B (PLB)-encoding genes that have
deacylation activity [3]. Although PLBs play a potential role as virulence factors, the
metabolic fate and function of the products of PLB turnover, the glycerophosphodiesters,
remain an open question [4-8]. This stands in stark contrast to our understanding of the
inositol-phosphates resulting from phospholipase C-mediated cleavage, for which
numerous kinases and phosphatases have been identified, and many metabolic
conversions clearly documented [9]. In addition, not all of the cell’s
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glycerophosphodiesters appear to be produced via C. albicans PLB activity and there is
growing evidence that this metabolic segregation, especially GroPIns and GroCho, may
be achieved by the occurrence of host phospholipase activity in organism [10-19].
In S. cerevisiae, GroPIns is transported into the cell via the transport protein,
ScGit1, encoded by the GIT1 gene. Four open reading frames (orfs) in C. albicans,
CaGIT1-4 contain significant sequence homology to ScGIT1 [20]. ScGit1 and CaGit1-4
are between 400-600 amino acids in length and contain either 12 or 14 membrane
spanning segments [21]. The C. albicans genome contains five PHS (phosphate: H+
symporter) family member: CaGit1-4 and Pho84, the homolog of the S. cerevisiae high
affinity phosphate transporter. Notably, none of these family members has been
characterized in C. albicans.
The method described here was developed to accurately determine the occurance
of GroPIns at nanogram levels or below in the media of C. albicans. In a biological
matrix, analytes can have different sizes, charges, polarities and hydrophobicities.
Chromatography techniques provide control of separation through changes in the mobilephase solvent content, the ionic strength, the pH, and the salt additives. Options for
optimal separations can be achieved through chromatographic mode, such as normalphase liquid chromatography (NPLC), reversed-phase liquid chromatography (RPLC),
hydrophilic interaction liquid chromatography (HILIC), and ion-exchange liquid
chromatography (IEX-LC). Approximately 80-90% of all HPLC analytical separations
apply RPLC as the separation mode. However, small polar compounds are often very
challenging to biological analysis. It is difficult to analyze polar analytes by RPLC due
to the lack of sufficient retention ability on reverse-phase columns. Although NPLC and
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IEX-LC can retain polar and charged compounds, their organic solvent contents in the
mobile phase have either high ionic strength or are not amenable to the electrospray
ionization environment in mass spectrometry. Moreover, ion pair separation of both acid
and a base in the same analysis is difficult.
HILIC is a viable complementary method to RPLC, NPLC, and IEX-LC and is
widely used for the separation of biologically active polar substances, such as amino
acids, peptides, carbohydrates, oligosaccharides, etc. The stationary phase of HILIC
column is composed of polar materials such as silica, amino or mixed mode, and its
mobile phase is mainly organic with aqueous solvent. Its mechanism of separation is
based on the ability of a polar analyte to partition into and out of adsorbed water and the
addition of a charged polar analyte to undergo cation exchange with charged silanol
groups. The combination of these mechanism results in enhanced polar retention while
lack of either of the mechanisms results in no polar retention [22-25]. Table 2-1
summaries the different methods for GroPIns separation. The separations of GroPIns
have mainly been done on anion-exchange columns [26, 27]. A microchip based
separation of phosphoinositides by micellar electrokinetic capillary chromatography
method was reported [28]. An amino-phase column was also applied to separate GroPIns
and other inositol phosphates using an acetate buffer in the mobile phase [29]. The above
techniques have the non-negligible disadvantage of being a multi-step procedure in which
the isotopic equilibrium of radiolabelled products is difficult to achieve. Recently, a LCMS/MS method using a β-cyclodextrin-bonded column was described for the quantitative
analysis of internal GroPIns in rat cell lines, but extracellular GroPIns was not included
in this method [30]. Another study used normal phase LC-MS to quantitate several
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water-soluble metabolites, including GroPIns and GroPCho, from rat brain tissue [31].
Our study differs from previous studies in that we use HILIC chromatography coupled
with MS/MS to detect GriPIns in the extracellular medium which has a high
concentration of other small molecules, including free phosphate.

Method

Analyte

Sample

Anion-Exchange

Detector

Reference

Liquid
GroPCho,

Hamster

GroPEth

ovary cells

column with Cation-

Scintillation

Exchange column

[27]

Counting
GroPIns,

Amino-Normal phase

Liquid
Human

Inositol
column

Scintillation

[29]

platelets
phosphates

Counting

Phenomenex NH2
GroPIns,

Mice brain

Normal Phase

Q-TOF MS
GroPCho

[30]

tissue

column
Triple
Nucleodex β-OH

Mice cell
GroPIns

Silica column

Quadrupole

[31]

lines
MS
GroPIns,

Waters Xbridge

GroPCho,

HILIC column

GroP, Inositol,

Yeast

Triple

Patton-

extracellular

Quadrupole

Vogt et al

medium

MS

(accepted)

Choline
Table 2-1 Summary of methods for separating and detecting GroPIns and GroPCho.
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HILIC overcomes the shortcomings of some of the other retention mechanisms
for extremely polar compound analysis. It retains highly polar analytes that would not be
retained by RPLC, and using a highly organic mobile phase promotes enhanced ESI-MS
response. In the tandem mass spectrometer, the analyte, GroPIns was dissociated by
collision gas to produce various product ions that could be monitored at the same time.
Liquid chromatography combined with tandem mass spectrometric detection was the
preferred method for quantitative analysis due to its intrinsic selectivity, sensitivity, and
speed in “omics” studies [33-36]. The expected fragmentation patterns of GroPIns are
shown in Figure 2-1. Although there are other methods available to study GroPIns, the
published methods mainly include radioactive analysis and have not added the absolute
quantification of the metabolites in the extracellular medium of a cell culture [37-39].
Our aim was to develop a novel HILIC-MS/MS method for quantification of GroPIns in
the extracellular medium of Candida albicans to monitor its uptake as a function of
growth.
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Figure 2-1 Expected fragmentation patterns of GroPIns by tandem mass spectrometry.

2.3 Materials and Methods
2.3.1 Reagents

The methanol and acetonitrile used for the LC-MS/MS analysis were Optima
grade from either Thermo Fisher Scientific (Pittsburgh, PA) or J.T. Baker (Phillipsburgh,
NJ). Distilled water was deionized with Barnstead Nanopure water system (Dubuque,
IA). The water was filtered with 0.22 μm Nylon membrane filters from either Millipore
(Billerica, MA) or Whatman International (Maidstone, England) prior to use. The mobile
phase for the HPLC analysis contained ammonium acetate (99% pure) from Thermo
Fisher Scientific in both acetonitrile and water. These solutions were made up fresh each
day and sonicated for 15 min in a 2210 Branson Ultrasonic cleaner (Danbury, CT) to mix
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and degas before use. Glycerophosphoinositol (L-α-glycerophospho-D-myo-inositol)
was from Sigma-Aldrich (St. Louis, MO).

2.3.2 Strains, Media and Culture Conditions

A wild type C. albicans strain DAY185 (ura3Δ::λimm434/ura3Δ::λimm434
pARG4::URA3::arg4::hisG/arg4::hisG pHIS1::his1::hisG/his1::hisG) was used in this
study. The strain in which the CaGIT1 gene was deleted was constructed in strain
DAY185 to produce git1::UAU1/git1::URA3 (JPV484). For insertional
complementation, plasmid pDDB78GIT1 was linearized and transformed into JPV484 to
produce JPV512 (git1::UAU1/git1::URA3 + pDDB78GIT1). Empty plasmid pDDB78
was also linearized and transformed into JPV484 to produce JPV526
(git1::UAU1/git1::URA3 + pDDB78). Insertional complementation or reintegration
delivers the GIT1 gene back into the mutant strain to test for reoccurrence of the wild
type transport function. The strains were grown aerobically over night at either 30°C or
37°C with shaking in low phosphate (Pi) yeast nitrogen base (YNB) media. Growth was
monitored by measuring the optical density at 600 nm (OD600) on a Biomate 3 Thermo
Spectronic spectrophotometer. Low Pi media were made by replacing the KH2PO4 (1
gm/liter) in YNB media with KCl (1gm/liter) and adding KH 2PO4 to 0.2 mM. The
cultures to be analyzed by MS grew in medium lacking KH2PO4 that contained 200 μM
(≈ 67 μg/mL) GroPIns. Immediately after inoculation, 1 mL of the samples were
removed in duplicate to obtain T=0 time point. Once the cultures were started, samples
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were taken at T=6 hours and T=24 hours. At each time point, 1 mL of the cultures was
removed, centrifuged to pellet the cells, and the supernatant filtered through the 0.22 μm
filters.

2.3.3 Standards and Sample Preparation

The primary solution of glycerophosphoinositol (13.4 mM) was diluted in water
to obtain aliquots of the standard compound at the concentration of 2 mM as stock
solutions. A working standard solution of GroPIns in 100 μg/mL was prepared from the
stock solution by dilution in water. The working standard solution was further serially
diluted in water to obtain eight calibration standard solutions of 2.5, 5, 10, 50, 100, 500,
1000 and 10000 ng/mL (approximately 7.5-30000 nM).
For the media samples from the above conditions, culture aliquots were
centrifuged at 3000 rpm for 5 min, and the resulting supernatant was filtered. 250 μL of
each media sample was then transferred into centrifuge tube and was diluted with 5 fold
volume of methanol/water, 90:10 (v/v) for centrifugation at 10,000 rpm for 5 min. The
supernatant was collected and dried under a stream of nitrogen. The residue was
resuspended in 250 μL of acetonitrile/methanol, 3:1 (v/v). Because the calibration curve
ranges over 2.5-10000 ng/mL (approximately 7.5-30000 nM) and 200 μM GroPIns was
in the media, was diluted the analyte in 1:100 fold volumes prior to analysis. Typically,
an injection volume of 10 μL was used and each sample was run in triplicate.
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2.3.4 Equipment and Experimental Parameters

The liquid chromatography with tandem mass spectrometry system (LC-MS/MS)
was composed of an Agilent 1200 Rapid Resolution LC system and an Agilent 6440
Triple Quadrupole Mass Spectrometer (Santa Clara, CA). The Mass Hunter software
package was used for the acquisition and processing of data. Quantification was
performed using Qualitative Analysis B1.0.82.2 as implemented in the Mass Hunter
software.
Electrospray ionization-tandem mass spectrometry (ESI-MS/MS) for
characterization, identification as well as quantification was performed in positive and
negative mode using product ion scan (PIS) and multiple-reaction monitoring (MRM)
respectively with a triple quadrupole mass spectrometer. PIS is a scan mode in which all
product ions fragmented from the selected molecular ion are detected in one run. MRM
was used to monitor the mass to charge ratios corresponding to the selected precursor and
product ions of interest; the program was set up to monitor several targeted ions at
different time segments in one run. The targeted ion dissociation pathway (Figure 2-2)

Figure 2-2 Scheme of collision induced dissociation of ions in triple quadrupole mass
spectrometer.
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for the above scan modes was optimized with regard to collision energy to minimize
variations in relative ion abundance due to differences in rates of dissociation. The
capillary voltage was maintained at 3.0 kV. The drying gas temperature was 300 °C and
the sheath gas temperature was 325 °C. The drying gas flow rate was set to 4 liters/min,
and the nebulizer pressure was 50 psi. The mass spectrum was acquired from m/z 501000 with the acquisition time same as the chromatography. The fragmentor voltage and
collision energy were optimized from 10-150 V and 0-100 eV. The optimal value of the
fragmentor voltage was manually adjusted to 90 V. The collision energy was optimized
to be 35 eV. The dwell time was set to be 200 ms for GroPIns.
The LC system, consisting of an Agilent binary pump and an Agilent highperformance autosampler, was used to provide the mobile phase and to inject samples.
For separation, a 5 μm XBridge column (150 x 4.60 mm, Waters, Milford, MA) was used
for hydrophilic interaction liquid chromatography (HILIC). The chromatography was
performed in isocratic elution at a flow rate of 0.5 mL/min when the mobile phase was
acetonitrile/water, 50:50 (v/v) with 10 mM ammonium acetate at pH 7.19. The relative
concentration of GroPIns in the media was selectively measured by multiple-reaction
monitoring and calculated by normalizing its peak area to the peak area of the relevant
external standards on calibration curve. All separations were carried out at the room
temperature (25 °C).
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2.4 Results and Discussion
2.4.1 Tandem Mass Spectrometry Optimization

In order to obtain lower detection limit of the analyte without compromising the
reliability of this method, a high selective MS/MS strategy rather than traditional
approaches such as UV detection was employed to ensure the specificity of detection.
The following conditions were applied for optimization experiments unless otherwise
noted. 10 μL of 1000 ng/mL GroPIns was loaded onto the column. A 20 min isocratic
elution was applied where the column was equilibrated in 50:50 acetonitrile/water before
each injection. After elution, the mobile phase was ramped linearly to 90:10
acetonitrile/water and was held over 10 min before returning to the initial conditions (5
min ramp). The mobile phase was then held at the initial conditions for 10 min before
doing the next injection. Ammonium acetate (10 mM) was in both the acetonitrile and
the water. The most relevant parameters in mass spectrometer to optimize are the
capillary voltage, source temperature and drying gas flow. The starting ESI-MS
parameters were as follows: capillary voltage 1.5 kV, drying gas temperature 100 °C, and
drying gas flow 2 liters/min. A high pressure liquid nitrogen dewar was used as the
nitrogen gas source. Once one of the above parameters had been optimized, its setting
was applied to optimize the other MS parameters in subsequent experiments. For these
experiments, the mass to charge ratio corresponding to the GroPIns being analyzed was
monitored throughout the analysis.
The capillary voltage is used at the entrance of the capillary and it is relative to
the nebulizer and spray chamber that are at ground potential. In order to optimize the
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setting for the capillary voltage, the rest of the MS parameters were held constant. The
capillary voltage was varied from 1.5 to 3.5kV. Analyte at 1000 ng/mL (≈ 3 μM) was
injected in triplicate at each voltage setting. The values of capillary voltage are slightly
different in positive and in negative ionization mode. The results in Figure 2-3 indicate
that a capillary voltage of 3.0 kV gave the largest signal as the optimum value.

Figure 2-3 Resulting peak intensities from injecting 1000 ng/mL (≈ 3 μM) of GroPIns into the
mass spectrometer while varying the capillary voltage setting. Results are the average of three
injections with the standard deviation.

A series of injections were conducted where all the parameters were held constant
except for the temperature of drying gas varying from 100 to 300 °C. Three replicates of
injections were done at each temperature setting. Results from varying the temperature
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are shown in Figure 2-4 that signal intensity increased with increasing drying gas
temperature. By comparing at the intensities, it was determined that 300 °C was the
optimal setting for the ESI source.

Figure 2-4 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass
spectrometer while varying the drying gas temperature setting. Results are the average of three
injections with the standard deviation.

An experiment was performed to optimize the drying gas flow; all the parameters
were held constant except for the drying gas flow. Three injections of 1000 ng/mL
analyte were done at each gas flow setting. The results are shown in Figure 2-5. This
experiment shows that the optimal drying gas flow setting was 4 liters/min. With these
conditions the analyte was detected by multiple reaction monitoring (MRM).

62

Figure 2-5 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass
spectrometer while varying the drying gas flow setting. Results are the average of three
injections with the standard deviation.

The nebulizer pressure was optimized by varying the setting from 30 to 50 psi,
while the other MS parameters were held constant. GroPIns (1000ng/mL) was injected in
triplicate at each pressure setting. The results are shown in Figure 2-6. The experiment
shows that the optimal nebulizer pressure setting was 50 psi and to some extend was flow
dependent.
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Figure 2-6 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass
spectrometer while varying the nebulizer pressure setting. Results are the average of three
injections with the standard deviation.

In order to assess the usefulness of ESI-MRM-MS/MS techniques for GroPIns
analysis, experiments were first conducted to establish the most efficient transition for
MRM. Electrospray ionization mass spectrometry in positive (+ESI) and negative (-ESI)
modes was performed for selective and sensitive detection. Full scan spectra were
acquired over the mass to charge ratio range of 50-1000. The precursor ion of GroPIns
([M-H]-) was detected at m/z 333.0 in –ESI (Figure 2-7).

64

Figure 2-7 Mass spectrum of the GroPIns in negative mode with total ion scan. GroPIns at 1000
ng/mL was injected.

To investigate the fragmentation of the analyte, product ion scan spectra were
acquired over the m/z range of 50-1000 for GroPIns (Figure 2-8). The most intense
fragment for GroPIns was selected for MRM analysis quantification with the following
parameters: m/z 333.0 → 153.0 for GroPIns ([M-Inositol-H]-), with a screen of
corresponding standards at 1000 ng/mL. To further improve MRM conditions, the effect
of fragmentor and collision energies over a range of different values were investigated by
separate loop injections with no column connected for best response of the most intense
precursor and product ions, respectively. The fragmentor voltage affects the transmission
and fragmentation of precursor ions. It helps the ions traverse the relatively high pressure
area between the exit of the capillary and skimmer. The maximum structural information
65

is achieved at higher voltage values. The analyte was first injected in the mobile phase
(50:50 acetonitrile/water with 10 mM ammonium acetate) and MS spectra were acquired
with a total cycle time of 500 ms and a dwell time of 200 ms.

Figure 2-8 Tandem mass spectrum of the GroPIns by product ion scan in negative mode. 1000
ng/mL of GroPIns was injected.

With the above settings of total cycle time and dwell time, an accurate evaluation
of a wide range of fragmentor voltage (10-150 V) in steps of 20 V for the studied analyte
were performed. Three injections of 1000 ng/mL GroPIns was done at each voltage
setting. The fragmentor voltage was optimized for best response of the precursor ion of
GroPIns, and the optimal fragmentor voltage was transferred to an MRM method for the
particular analyte (Figure 2-9). While the optimal fragmentor voltage was determined at
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90 V, values for collision energy varied for the studied analyte and needed to be analyzed
as well.

Figure 2-9 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass
spectrometer while varying the fragmentor voltage setting. Results are the average of three
injections with the standard deviation.

A second injection was made to optimize the collision energy. Since different
precursor ions have different collision stabilities, good product ion yields are achieved
with minimum losses in the overall ion current. The precursor ion was transmitted
through the first quadrupole (Q1) into the collision cell (Q2), fragmented and
corresponding fragments were monitored through third quadrupole (Q3). The product
ion spectra were acquired at different collision energies ranging from 0 to 100 eV in steps
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of 10 eV. The collision energy was evaluated for best response of the most intense
product ion. As shown in Figure 2-10, the intensities of the precursor ions of the analyte
decreased when the collision energy increased. At the meantime, the signals of its
product ions increased at first and then decreased. The optimal collision energy was
selected and also transferred to the MRM. This process for optimization was repeated for
GroPIns and the MRM conditions were stored before sample acquisition.

Figure 2-10 Resulting peak intensities from injecting 1000 ng/mL of GroPIns into the mass
spectrometer while varying the collision energy setting. Results are the average of three
injections with the standard deviation.

The optimized MS parameters for GroPIns detection were as follows: capillary
voltage 3.0 kV, fragmentor voltage 90 V, collision energy 35 eV, drying gas temperature
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300 °C, sheath gas temperature 325 °C, drying gas flow 4 liters/min, and the nebulizer
pressure 50 psi. More analytes were added once the MS parameters had been optimized
in order to evaluate the separation conditions on the HILIC column.

2.4.2 Liquid Chromatography Optimization

Chromatographic conditions, especially composition and nature of the mobile
phase is crucial for LC separation as this has significant impact on retention time of the
analyte, peak shapes, sensitivity and therefore on the overall separation efficiency.

Base

on literature survey water was selected as the strong solvent that is more polar than
acetonitrile to elute polar analytes as the polarity of the mobile phase was increased by
increasing the percentage of water. Analysis of analytes was initiated under isocratic
conditions with an aim to develop a simple separation process with a short time.
Separation was optimized using various combinations of mobile phase between water and
acetonitrile. Unless otherwise noted, the optimized MS/MS parameters were applied.
According to the manufacture’s instruction, the new column was at first flushed
for 50 column volumes (125 mL) of 50:50 acetonitrile/water (v/v) with 10 mM
ammonium acetate. The column was then equilibrated with 20 column volumes (50 mL)
of initial mobile phase conditions prior to making first injection. Other conditions were
also considered for best results. At least 5% water was maintained in the mobile phase to
ensure that column particle is always hydrated, which could greatly reduce the column
equilibration time and thus ensure stable retention times. For best reproducibility, a
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blank sample at the beginning of each sample set was injected. Additionally when using
an autosampler, a needle wash step with acetonitrile was incorporated.
Mobile phase combination with acetonitrile: water was performed with different
ratios (90:10, 80:20, 70:30, 50:40, 50:50 v/v) in isocratic mode. The initial elution was
20 min long with constant flow rate at 0.5 mL/min and after that the column was
equilibrated in 90:10 acetonitrile/water for 10 min. The mobile phase was then ramped
linearly to the initial conditions over 5 min and was held at the initial conditions for 10
min before doing the next injection. Ammonium acetate (10 mM) was in both the
acetonitrile and the water. Figure 2-11 shows the retention time increased as the
composition of acetonitrile in the mobile phase increased. As more acetonitrile was
added to the mobile phase, the elution time for GroPIns was slowed down. In other
words, by adding more water to the initial conditions (50:50 acetonitrile/water) the peak
was obtained at retention time of 13.06 ± 0.15 min for GroPIns with total run time of 20
min (Figure 2-12).
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Figure 2-11 Changes of the retention time of GroPIns on the XBridge HILIC column while varying
the composition of acetonitrile in the mobile phase. Results are the average of three injections
with the standard deviation.

Figure 2-12 LC-MS/MS separation and detection of GroPIns. 10 μL of the analyte at 1000 ng/mL
was injected. m/z 333.0 → 153.0 for GroPIns was monitored in MRM mode.
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In order to evaluate the effect of buffer in the mobile phase, injections of the
GroPIns at 1000 ng/mL were conducted in triplicate for the varying concentrations of
ammonium acetate (2.5, 5, 7.5, 10, 15 and 20 mM) in the mobile phase. The
concentration of ammonium acetate had to be optimized to improve the ionization of the
metabolites in the ESI-MS/MS source. For these experiments, the peak areas of GroPIns
were monitored. Figure 2-13 shows the resulting peak areas as the concentration of
ammonium acetate was changed for the analyte. The experiments conclude that 10 mM
ammonium acetate in the mobile phase gave the best ionization efficiency of the analyte
when using ESI source. The mobile phase was required to be prepared daily to prevent
the degradation of the buffer.

Figure 2-13 Resulting peak areas from injecting 1000 ng/mL of GroPIns on the XBridge HILIC
column while varying concentration of ammonium acetate in the mobile phase. Results are the
average of three injections with the standard deviation.
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After the buffer in the mobile phase had been optimized, the detection limit was
investigated using 10 mM ammonium acetate in the mobile phase. The isocratic elution
was the same as above with the flow rate of 0.5 mL/min directed into the MS. A series of
injections were conducted, varying the concentrations of GroPIns loaded over two orders
of magnitude. Representative chromatograms at the lowest standard injected are
presented in Figure 2-14. The results indicate that the detection limit for GroPIns was
generally 2.5 ng/mL (≈ 7.5 nM) when using this method. Adequate sensitivity was
observed for the lowest calibration standard. From running these experiments, it was
shown that the cleanness of the capillary, the chamber vacuum seal, and the gas flow
affected the ionization of the lipid metabolites. It was also important for the mobile
phase with ammonium acetate to be prepared daily to prevent the buffer from degrading.
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Figure 2-14 LC-MS/MS separation and detection of GroPIns. 10 μL of the analyte from 2.5 to
10000 ng/mL was injected. Eight chromatograms are shown where the same isocratic elution
was used, but the concentration of the analyte was varied.

2.4.3 Method Performance

Quantification was performed by comparison of the analyte peak area versus an
external calibration curve. The external calibration curves were generated by using eight
calibration standards with different concentrations ranging from 2.5 to 10000 ng/mL.
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The calibration curve standards were prepared in three replicates for analysis. The
results were fitted to least-squares linear regression analysis. Figure 2-15 shows that the
analyte has good linearity. Correlation coefficient of the calibration curves for GroPIns is
0.9962.

Figure 2-15 Calibration curve of the log of the average peak area of GroPIns standard versus the
log of the corresponding concentration (ng/mL).

In order to evaluate the reproducibility of the results from run to run, 10
successive injections of GroPIns at 1000 ng/mL were conducted on one day. Results are
shown in Figure 2-16. The coefficient of variation (relative standard deviation) in the
peak was calculated to be 3.1% for GroPIns.

75

Figure 2-16 Plot of the peak areas from GroPIns over the course of 10 successive injections.

The extraction recovery of the analyte was evaluated by comparing the peak areas
of medium spiked with standards at the concentrations of 500 and 1000 ng/mL in three
replicates to those of blank medium extracts spiked with standards at equivalent
concentrations after a single step liquid-liquid extraction. The mean extraction recovery
was 82.3% for GroPIns. No significant degradation occurred under experimental
conditions. These results indicate the adequate reliability and reproducibility of this
method within the analytical range.
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2.4.4 Determination of GroPIns Uptake in Candida albicans

The developed LC-MS/MS method was employed to monitor the levels of
GroPIns in the medium as a function of growth in Candida albicans in order to obtain
evidence for the transport of GroPIns across the plasma membrane. A wild type strain
DAY185 (JPV484), a homozygous insertional mutant of CaGIT1 (JPV526), and a
homozygous insertional mutant bearing reintegrated CaGIT1 (JPV512) were grown over
24 hours. 1 mL of media samples from each strain were taken in triplicate during the
culture processes at T=0, 6 and 24 hours. Samples were prepared as described in section
2.2.3 and were analyzed using the optimized LC-MS/MS method. We first monitored the
culture media spiked with 200 μM GroPIns to get a zero time reading and again after 6
and 24 hours of growth, at which points the GroPIns remaining in the media were
monitored (Figure 2-17). A decrease in GroPIns levels in wild type strain (85.17 ± 0.93
μM at 6 hours and 1.3± 0.01 μM at 24 hours) and a decrease in GroPIns levels in
homozygous insertion mutant bearing a reintegrated copy of CaGIT1 (125.5 ± 1.05 μM at
6 hours and 1.3 ± 0.01 μM at 24 hours) were observed in Figure 2-17. In contrast, there
was no decrease in the GroPIns peak for the homozygous git1-/git1- mutant (162.33 ±
0.96 μM at 6 hours and 178.43 ± 1.50 μM at 24 hours). The fact that the levels of
GroPIns in the medium decreased or remained the same depending on the presence of the
CaGIT1 gene indicates that the depletion of GroPIns levels from the medium is
dependent upon CaGIT1.
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Figure 2-17 Determination of GroPIns concentrations from extracellular media of Candida
albicans in wild type cells, a homozygous insertional mutant of CaGIT1 (git1-/- +pDDB78), and a
homozygous insertional mutant bearing reintegrated CaGIT1 (git1-/- +pDDB78GIT) after 0, 6, and
24 hours. Because the analytes were diluted in 1:100 fold volumes before injection, the
concentrations of GroPIns in the figure were calculated by multiplying the values detected in the
MS by 100. Values represent mean ± S.E. of triplicate determinations.

2.5 Conclusions

A new chromatographic method was developed for analyzing a small polar lipidrelated metabolite, glycerophosphoinositol, in extracellular medium of C. albicans. The
developed method has high reproducibility, a low limit of detection, and high selectivity.
It requires standard instrumentation with an isocratic HPLC system and a HILIC column
which is readily adapted to tandem mass spectrometry detection. The time for a single
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run analysis is less than 15 min. The analysis time could be reduced through automation
and by using a gradient elution for HPLC. This method was successfully applied in a
metabolic study for the determination of GroPIns uptake in C. albicans. The application
of the approach described in this Chapter has contributed to the publication in the
Eukaryotic Cell journal (Bishop et al., 2011).
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Chapter 3

Simultaneous Quantification of Lipid-Related
Extracellular Metabolites in Saccharomyces cerevisiae
using HILIC-MS/MS: Application in Metabolomic Study1

1

The work described in this Chapter is presented in the following manuscript:

Sun, T.; Wetzel, S. J.; Johnson, M. E.; Surlow, B. A.; Patton-Vogt, J. Development and
validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry
method for the quantification of lipid-related extracellular metabolites in Saccharomyces
cerevisiae, Journal of Chromatography B, 2012, Accepted pending revisions.
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3.1 Abstract

In this Chapter, a highly sensitive hydrophilic interaction liquid chromatographytandem mass spectrometry (HILIC-MS/MS) method was developed and validated for the
quantification of glycerophosphoinositol (GroPIns), glycerophosphocholine (GroPCho),
glycerol 3-phosphate (GroP), inositol, and choline in the extracellular medium of
Saccharomyces cerevisiae. The media samples were pretreated with a single two-phase
liquid extraction. Chromatographic separation was achieved on a Waters Xbridge HILIC
(150×4.6 mm, 5 μm) column under isocratic conditions using a mobile phase composed
of acetonitrile/water, 70:30 (v/v) with 10 mM ammonium acetate at a flow-rate of 0.5
mL/min. Using a triple quadrupole tandem mass spectrometer, samples were detected in
multiple reaction monitoring (MRM) mode via an electrospray ionization (ESI) source.
The calibration curves were linear (r2≥0.995) over the range of 0.5-150 nM, with the
lower limit of quantitation validated at 0.5 nM for all analytes. The intra- and inter-day
precision ranged from 1.24 to 5.88% and 2.46 to 9.77% (CV%), respectively, and intraand inter-day accuracy was between -8.42 to 8.22% and -9.35 to 6.62% (RE%),
respectively, at all quality control levels. The extracellular metabolites were stable
throughout various storage stability studies. The fully validated method was successfully
applied to determine the extracellular levels of phospholipid-related metabolites in S.
cerevisiae.
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3.2 Introduction

The metabolome represents the full collection of low-molecular weight chemical
species within a cell or biological system, and is considered the endpoint of “omics
analysis” [1-3]. Current research on metabolomic investigation consists of four
complementary approaches: target analysis, metabolic profiling, metabolic fingerprinting,
and metabolic footprinting [4-6]. All of these approaches are usually applied to
investigate differences in metabolite concentrations after alterations in the biological
environment or upon genetic modification. The measurement of extracellular metabolites
secreted from the intracellular volume into the growth medium is termed “metabolic
footprinting”. Footprinting analysis offers important technical advantages over the
analysis of intracellular compounds, referred to as “metabolic fingerprinting” [7-9]. First
of all, the extracellualar metabolome is generally quite stable owing to the relative lack of
enzymes that can convert the metabolites into other products. Therefore, the timeconsuming quenching steps associated with the analysis of intracellular metabolites are
not required when extracellular metabolites are analyzed. In addition, the extracellular
metabolome is generally simplified in terms of the number of metabolites present and
their concentration ranges as compared to the intracellular metabolome, but can still
provide important insight into cellular metabolism [7]. Metabolic footprinting has been
used in the classification of microbial mutants for functional genomics studies by
employing mass spectrometry (MS) [3, 10-12] or nuclear magnetic resonance (NMR)
analysis [13]. For yeast and mammalian cells, metabolic footprinting has been performed
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under a limited number of conditions, and has primarily focused on central carbon
metabolites [14-18]. To our knowledge, no metabolic footprinting study has focused on
lipid metabolites.
The simple eukaryote, Saccharomyces cerevisiae, has been used as a model to
study many aspects of cell biology, including lipid metabolism [19-23]. We have chosen
to monitor five major phospholipid metabolites in the media of S. cerevisiae: inositol,
choline, glycerol 3-phosphate, glycerophosphoinositol, and glycerophosphocholine
(Table 3-1). The lipid precursors inositol and choline regulate phospholipid biosynthesis
at the transcriptional level in S. cerevisiae [24]. Thus, they are frequently added to and
removed from medium to study and manipulate the biosynthetic pathways. In addition,
inositol and choline can be produced by the cell via lipid turnover events. We chose to
monitor GroP as it represents a metabolite that could be produced through phospholipid
turnover, and is also a metabolic precursor involved in phospholipid biosynthesis.
Finally, extracellular GroPIns and GroPCho are produced through the hydrolytic
cleavage of both acylester bonds of plasma membrane-associated glycerophospholipids
by phospholipase B type enzymes [20, 21, 25]. Thus, extracellular GroPIns and
GroPCho can be monitored as an indicator of phospholipase B activity encoded by the
PLB1, PLB2, and PLB3 genes. Overall, the concentration of each of these metabolites in
the medium is the result of two processes: their production via enzymatic activity and
their uptake via plasma membrane transport.
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Name

Structure

Glycerophosphoinostol

Glycerophosphocholine

Glycerol 3-phosphate

Inositol

Choline

Choline-d9

Table 3-1 Molecular structures of five lipid-related metabolites and internal standard.
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This method was developed in order to create a simplified and sensitive method for
the absolute and simultaneous quantitation of the levels of important phospholipid
metabolites in the media of S. cerevisiae. Previous studies in which one or more of the
compounds has been monitored usually involve the use of radioactivity, as the
compounds have no UV or fluorescence detectable groups. For example, 3H or 14C
labeled inositol or choline, and 32P-H3PO4 are typically utilized [26-28]. However,
measuring all of these compounds simultaneously with multiple radioactive compounds
is technically challenging, even if a good separation system is at hand. In addition, the
use of radioactive molecules can also present a quantitation problem. For example, since
S. cerevisiae can both synthesize and import inositol and choline, radioactive labeling
only allows for the discrimination of inositol and choline transported into the cell, not
that derived from de novo synthesis. In contrast, MS detects all chemical species,
regardless of their mode of synthesis. Finally, the method described here is an advance in
terms of the LC separation of the compounds. While published procedure has described
the chromatographic separation of choline-containing metabolites, and inositolcontaining metabolites, we know of no published procedure for the LC separation of all
five of these compounds simultaneously [ 29-31].
Two published studies are pertinent to the method described here. A LC-MS/MS
method using a β-cyclodextrin-bonded column was described for the quantitative analysis
of internal GroPIns in rat cell lines, but other metabolites were not included in this
method [32]. Another study used normal phase LC-MS to quantitate several watersoluble metabolites, including GroPIns and GroPCho, from rat brain tissue 33. Our
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method differs from that of Kopp et al [33] in that we perform extensive method
validation, we analyze an overlapping but different set of metabolites, and we use HILIC
chromatography, which results in decreased retention times as compared to normal phase.
Here, we present a hydrophilic interaction liquid chromatography-tandem mass
spectrometry (HILIC-MS/MS) method for the quantification of five lipid-related
extracellular metabolites in S. cerevisiae cells. A liquid-liquid extraction procedure has
been combined with an extensive optimization of HILIC-MS/MS methodology to provide
effective and reliable chromatographic separation of analytes in the supernatant of
extracellular medium. The method is highly sensitive and has been thoroughly validated
according to the bioanalytical method validation guidelines for industry as specified by
the US Food and Drug Administration (FDA) (www.fda.gov/downloads /Drugs/Guidance
ComplianceRegulatoryInformation/Guidances/ucm070107.pdf).

3.3 Experimental
3.3.1 Materials and Regents

Standard compounds including glycerophosphoinositol (L-α–glycerophospho –D–
myo-inositol), glycerophosphocholine (L-α–glycerophosphorylcholine), glycerol 3phosphate (L-α–glycero-phosphate), myo-inositol, and choline chloride were purchased
from Sigma-Aldrich (St. Louis, MO, USA). The deuterated internal standard (IS),
choline chloride-d9, was obtained from Cambridge Isotopes (Andover, MA, USA).
Ammonium acetate was purchased from Fisher Scientific (Pittsburgh, PA, USA).
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Optima grade methanol and acetonitrile used for LC-MS/MS analysis were also
purchased from Fisher Scientific. Deionized water was obtained using a Milli-Q water
purification system from Millipore (Bedford, MA, USA).

3.3.2 Preparation of Standard Solutions and Quality Control Samples

Primary stock solutions of glycerophosphoinositol (GroPIns), glycerophosphocholine (GroPCho), glycerol 3-phosphate (GroP), myo-inositol, choline chloride, and
choline chloride-d9 (IS) were prepared in methanol/water, 1:1 (v/v) at a concentration of
50 mM, respectively. Working standard solutions were made by diluting the primary
stock solutions in water to a concentration of 10 μM. A working standard solution of the
internal standard (choline-d9) in 2.5 μM was prepared by diluting its primary stock
solution in deionized water. Eight calibration standards were prepared by adding 25 μL
aliquots of appropriate dilution of the working standard solutions and internal standard to
475 μL aliquots of the blank medium to obtain the following concentrations: 0.5, 1.5, 5,
10, 30, 60, 90 and 150 nM. Quality control (QC) samples were prepared at
concentrations of 2 nM (low QC, LQC), 50 nM (middle QC, MQC), and 100 nM (high
QC, HQC) by spiking the blank media with the working standard solutions. The primary
stock solutions, working standard solutions and QC samples were stored at -20°C until
use.
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3.3.3 Culture Conditions and Sample Preparation

The S. cerevisiae wild type strains, BY4741 (JPV203, MATa his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and BY4742 (JPV399, MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) were
purchased from Open Biosystems (Thermo Scientific, Huntsville, AL, USA). The
deletion strains were constructed using standard homologous recombination techniques.
Drug resistant markers, hph, KanMX, and nat1 were amplified from plasmids pAG32,
pUG6, and pAG25, respectively, and were inserted in place of the target genes for
deletion. The plasmids were received from Euroscarf [34, 35]. Deletion strains were
constructed in JPV203 to produce plb1::hph (JPV617), plb2::KanMX (JPV618),
plb3::nat1 (JPV 619), plb1::hph/plb2::KanMX/plb3::nat1 (JPV623), and in strain
JPV399 to produce plb1::hph (JPV668). Strains were grown aerobically at 30°C in yeast
nitrogen base (YNB) medium containing 75 μM inositol, 20 μM choline, and 2 mM
KH2PO4 instead of normal 7.35 mM KH2PO4 in order to minimize ion suppression in
mass spectrometry. Growth was monitored by measuring the OD 600 nm using a
Biomate 3 Thermo Spectronic spectrophotometer.
To prepare medium samples, culture aliquots were centrifuged at 3000 rpm for 5
min, and the resulting supernatant was filtered. A liquid-liquid extraction approach was
performed in order to separate polar lipid metabolites from the non-polar materials in the
extracelluar medium. 10 μL of internal standard working solution and 100 μL aliquots of
the metabolite containing supernatant were added to 890 μL of chloroform/methanol, 2:1
(v/v). This mixture was vortexed for 2 min, followed by centrifugation at 3000 rpm for 3
min. A 200 μL aliquot of the upper phase (49.3 ± 1.0% of the total analytes) was
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collected and transferred into a 1.5-mL HPLC vial for evaporation under nitrogen. The
residue was reconstituted in 200 μL of acetonitrile/methanol, 75:25 (v/v) and was diluted
in 1:100 fold volumes before analysis. The sample injection volume to LC-MS/MS
system was 10 μL.

3.3.4 Instrumentation

Chromatographic studies were performed via a 1200 series Rapid Resolution LC
system coupled with a 6440 Triple Quadrupole Mass Spectrometer (Agilent, Santa Clara,
CA, USA). MassHunter workstation software package was used for data acquisition and
processing. Quantification was determined using Qualitative (B1.0.82.2) and
Quantitative (B1.0.77.3) Analysis as implemented in the MassHunter software.

3.3.4.1 Chromatographic Conditions

The analytical column used was a Waters Xbridge HILIC (150×4.6 mm, 5 μm)
column from Waters Corporation (Milford, MA, USA). Separations were performed
under isocratic conditions at a flow rate of 0.5 mL/min at room temperature. Mobile
phase consisted of acetonitrile/water, 70:30 (v/v) with 10 mM ammonium acetate at pH
4.5. Column effluent was then passed through the mass spectrometer for later detection.
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3.3.4.2 MS Settings

Electrospray mass spectrometry (ESI-MS) was performed on a triple quadrupole
mass spectrometer. Mass transitions of m/z for each metabolite and IS were optimized
by direct infusion of the respective analytes in acetonitrile/water, 70:30 (v/v) with 10 mM
ammonium acetate in product ion mode. Optimum settings for subsequent LC-MS
analyses were manually adjusted. Metabolites were detected in both positive and
negative ionization modes at different time segments in one run using multiple reaction
monitoring (MRM). Other MS parameters were set as follows: capillary voltage of 3.5
KV, drying gas temperature of 300°C, fragmentor voltage of 50 V, and sheath gas
temperature of 325°C. Sheath gas flow and drying gas flow rates (both are nitrogen)
were set at 10 and 8 L/min, respectively. Low and high mass resolutions were fixed at 15
(arbitrary units) for both the first and third quadrupole mass analyzers. Dwell time and
interchannel delay were maintained at 200 and 10 ms, respectively. Collision energy in
the rf-only quadrupole cell and transitions were optimized for each metabolite on the
reference compound. The starting parameters of ESI source for small molecules from the
manufacture’s instruction are illustrated in Table 3-2.

Flow dependent parameters

Compound dependent parameters

Nebulizer pressure

30 psi

Capillary voltage

2 kV

Drying gas flow

5 L/min

Fragmentor voltage

10 V

Drying gas temperature

200 °C

Collision energy

0 eV
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Sheath gas flow

8 L/min

Sheath gas temperature

250 °C

Table 3-2 Starting parameters for ESI source optimization.

3.3.5 Method Validation

The LC-MS/MS method was validated through evaluation of specificity, linearity,
sensitivity, intra- and inter-day precision, accuracy, recovery, and stability in accordance
with currently approved FDA bioanalytical method validation guidelines.

3.3.5.1 Specificity and Selectivity

To determine if endogenous contaminants were present in coelution with the
analytes, the chromatography was developed and the MS/MS parameters were optimized
to obtain separation of the analytes from potentially interfering compounds as well as the
highest signal to noise ratios.

3.3.5.2 Linearity of Calibration Standards, Precision, and Accuracy

Linearity was evaluated over the concentration range of 0.5 to 150 nM. The
calibration curve was constructed by plotting the peak area ratio of analyte to that of IS
against the nominal concentration of calibration standards. The results were fitted to
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least-squares linear regression analysis with a correlation coefficient of 0.995 or better.
Intra-day and inter-day precision and accuracy were determined through analysis of six
replicates at four different levels (0.5, 2, 50 and 100 nM) during the same day and on
three different days. The precision was determined by calculating the coefficient of
variation (CV), and the accuracy was expressed in the form of the relative error (RE),
which was calculated as the percent deviation of the mean from the true value. The
acceptance criteria of the data included precision within ±15% CV from the nominal
values and an accuracy of within ±15% RE, except for LLOQ, where it should not exceed
±20% of accuracy as well as precision (Bioanalytical method validation guidelines of
FDA).

3.3.5.3 Recovery

The extraction recoveries of analytes from medium were determined by comparing
the mean peak areas of medium spiked with standards at three levels (2, 50 and 100 nM,
n=6) to those of blank medium extracts spiked with standards at equivalent
concentrations, corrected for the evaporated volume of organic phase. The recovery of
the internal standard was determined at a concentration of 50 nM.
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3.3.5.4 Matrix Effect

Matrix effects from the medium samples were evaluated by comparing the peak
areas of the spiked blank medium extracts (2, 50 and 100 nM, n=6) to the peak areas
from standards spiked in mobile phase of acetonitrile/water, 70:30 (v/v) with 10 mM
ammonium acetate.

3.3.5.5 Stability

The stability of analytes in medium was investigated using QC samples (2 and 100
nM) stored under different temperature conditions for different periods of time. The six
replicates were subjected to three freeze (12, 18 and 24 h) – thaw (2, 3 and 4 h) cycles.
Short-term storage stability was evaluated at room temperature for 4 h, and long-term
storage stability at -20°C for 30 days. Reinjections of QC samples (n=6) were analyzed
after 24 h storage at the same concentrations in the autosampler.

3.4 Results and Discussion
3.4.1 Optimization of MS/MS Conditions

The Agilent triple quadruple mass spectrometer applies Jet stream technology, of
which the super-heated sheath gas collimates the nebulizer spray and presents more ions
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to the MS inlet. The source optimization for ESI-MS system is composed of two main
parameters: flow dependent parameters and compound dependent parameters. The flow
dependent parameters include nebulizer pressure, drying gas temperature and flow and
sheath gas flow, while the compound dependent parameters consist of capillary voltage,
fragmentor voltage, collision energy and sheath gas temperature. All the parameters had
a substantial effect on the MS/MS determination of the analytes and thus their adjustment
was crucial. The optimum conditions for the determination of the metabolites by triple
quadruple MS/MS extracted from this experiment are summarized in Table 3-3.
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The standards of the analytes were first characterized by total ion scan and product
ion scan through direct infusion to ascertain their precursor ions and to select product
ions for use in MRM mode. Voltages and gas flow changed quickly and were optimized
with series of flow injections. Temperatures including sheath gas and drying gas needed
equilibration time between injections. The MS/MS parameters, specifically fragmentor
voltage and collision energy, were evaluated for the best response of the parent ion and
daughter ion, respectively, using the starting parameters above for ESI source and then
transferred to the MRM method. Long dwell times were required for obtaining better
sensitivity. GroPCho, GroP, and choline were found to give the most intense protonated
molecular ions under positive ionization, while GroPIns and inositol were detected in
negative ionization mode. The m/z values of precursor ions and fragment ions for each
analyte are illustrated in Table 3-4.

Analyte

Ionization
mode (m/z)

Precursor
ion (m/z)

Transition
pairs (m/z)

Choline

Positive

104.1

104.1→60.1

Choline-d9

Positive

113.1

113.1→69.1

GroP

Positive

172.7

172.7→98.8
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Main fragmentation
structure

Inositol

Negative

178.7

178.7→86.8

GroPCho

Positive

258.0

258.0→104.0

GroPIns

Negative

333.0

333.0→152.9

Table 3-4 Precursor ions, transition pairs and the corresponding main fragmentation structures
for the analytes and internal standard.

Full scan spectra produced a predominant peak for [M+H] + at m/z 258.0 of
GroPCho, 172.7 of GroP, 104.1 of choline, and 113.1 of internal standard, respectively.
The deprotonated molecular ions [M-H]- of GroPIns and inositol were detected at m/z
333.0 and 178.7, respectively. Collision induced dissociation of the precursor ions
produced major fragmentation for each analyte. Therefore, the transition pairs
258.0→104.0 (Figure 3-1), 172.7→98.8 (Figure 3-2), 104.1→60.1 (Figure 3-3), and
113.1→69.1 (Figure 3-4) were optimized for GroPCho, GroP, choline, and choline-d9,
respectively. Using similar procedures, the MRM transition of GroPIns and inositol were
determined to be 333.0→152.9 (Figure 3-5), and 178.7→86.8 (Figure 3-6), respectively.
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Figure 3-1 Tandem mass spectra of the GroPCho by product ion scan in positive mode.

Figure 3-2 Tandem mass spectra of the GroP by product ion scan in positive mode.
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Figure 3-3 Tandem mass spectra of the choline by product ion scan in positive mode.

Figure 3-4 Tandem mass spectra of the choline-d9 by product ion scan in positive mode.
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Figure 3-5 Tandem mass spectra of the GroPIns by product ion scan in negative mode.

Figure 3-6 Tandem mass spectra of the inositol by product ion scan in negative mode.
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3.4.2 Optimization of LC Conditions

Polar lipid-related metabolites were extracted from the extracellular medium by a
liquid-liquid extraction. Chloroform/methanol, 2:1 (v/v) was used as the extraction
solvent to remove non-polar compounds from the medium. The choice of a
chromatography method was less straightforward since a diverse range of metabolites at
widely differing concentrations are present in culture medium. A HILIC column was
chosen as an appropriate approach based on a review of the literatures for smaller
hydrophilic and ionizable analytes [36-45]. A Waters Xbridge HILIC (150×4.6 mm, 5
μm) column was selected to provide the best compromise between specificity and speed
of analysis. With the optimum isocratic elution, the metabolites were adequately
separated with retention times of 5.58 min for inositol, 15.47 min for GroP, 15.68 min for
GroPIns, 5.39 min for GroPCho, and coelution of choline and choline-d9 at 3.38 and 3.37
min, respectively (Figure 3-7B).

3.4.3 Method Validation
3.4.3.1 Specificity and Selectivity

Representative chromatograms of blank medium, a spiked medium sample, and the
medium obtained after growth of a wild type strain were shown in Figure 3-7. No
interference with the retention time of the analytes and internal standard (Figure 3-7B and
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3-7C) was observed in the blank medium (Figure 3-7A), indicating the specificity of the
present method.

Figure 3-7 Representative LC-MS/MS chromatograms of (A) a blank medium (noise baseline), (B)
medium sample spiked with analytes and internal standard at 0.5 nM (LLOQ), and (C) medium
from a wild type strain (JPV203) spiked with internal standard at 0.5 nM.
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3.4.3.2 Linearity of Calibration and LLOQ

The calibration curves were constructed by plotting the instrument response (peak
area ratio (analyte/IS)) versus calibration standard concentration. A linear relationship
was constructed over the concentration range of 0.5-150 nM. Correlation coefficients (r 2)
of the calibration curves for all standards ranged between 0.995 and 0.997 (Figure 3-8, 39, 3-10, 3-11 and 3-12). The precisions (CV%) were less than 8.7%, and the accuracies
(RE%) were within the range of -6.2 to 8.3% in Table 3-5. Using the present method, the
LLOQ was validated at 0.5 nM for all analytes, which is equivalent to 186, 129, 185, 90
and 70 pg/mL for GroPIns, GroPCho, GroP, inositol, and choline, respectively. Under
the present LLOQ, the concentration of analyte in the medium can be determined even 24
h after administration. As a result, this method was sensitive enough to investigate the
levels of these metabolites in the exometabolome of S. cerevisiae.
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Figure 3-8 Plot of the peak area ratio of GroPIns to internal standard versus the concentration of
GroPIns.

Figure 3-9 Plot of the peak area ratio of GroPCho to internal standard versus the concentration of
GroPCho.
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Figure 3-10 Plot of the peak area ratio of GroP to internal standard versus the concentration of
GroP.

Figure 3-11 Plot of the peak area ratio of inositol to internal standard versus the concentration of
inositol.
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Figure 3-12 Plot of the peak area ratio of choline to internal standard versus the concentration of
choline.

3.4.3.3 Recovery

The mean extraction recoveries of analytes in Table 3-7 were 74.4% for GroPIns,
72.6% for GroPCho, 80.7% for GroP, 82.5% for inositol, 75.9% for choline, and 75.5%
for IS at 50 nM. The simple sample extraction procedure with 10 volumes of
chloroform/methanol, 2:1 (v/v) to 1 volume of sample allowed for high sample
throughputs and good recoveries. No significant degradation occurred under any
experimental condition.
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Analyte
0.5
GroPIns
Mean
Precision (CV%)b
Accuracy (RE%)c
GroPCho
Mean
Precision (CV%)
Accuracy (RE%)
GroP
Mean
Precision (CV%)
Accuracy (RE%)
Inositol
Mean
Precision (CV%)
Accuracy (RE%)
Choline
Mean
Precision (CV%)
Accuracy (RE%)

1.5

0.47 1.52
3.44 2.79
-6.24 1.33

Nominal concentration (nM)
5
10
30
60
90

150

5.06
6.82
1.24

9.73
5.40
-2.75

31.84 63.92
4.27 6.98
6.13 6.53

94.21
3.18
4.68

146.62
4.02
-2.25

0.50
4.29
0.03

1.47 4.93 10.44
8.70 3.37 6.13
-2.73 -1.42 4.42

30.37 62.82
4.28 3.27
1.23 4.75

92.29
4.91
2.54

145.22
2.47
-3.19

0.52
4.25
4.20

1.46
1.57
2.67

5.09
3.81
1.83

9.52
2.39
-4.88

29.64 57.28
5.07 2.73
1.21 -4.53

88.74
4.20
-1.45

146.25
3.31
-2.58

0.46
2.55
8.31

1.58
4.98
5.33

5.12
6.96
2.46

10.67
3.38
6.70

30.88 58.73
5.26 3.01
2.93 -2.12

93.64
2.29
4.04

147.27
4.47
-1.82

0.51
3.01
2.11

1.54
6.28
2.67

4.85 9.82
4.11 5.26
-3.31 -1.87

29.64 62.49
4.42 1.57
-1.22 4.15

85.26
2.06
-5.27

145.72
6.31
-2.85

Table 3-5 Precision and accuracy of calibration samples (n=6 in 3 runs). The coefficient of
variation (CV%) = [Standard deviation/mean concentration measured] × 100. The relative error
(RE%) = [(mean concentration measured-nominal concentration)/nominal concentration] × 100.

3.4.3.4 Precision and Accuracy

Table 3-6 is a summary of the intra - and inter-day precision and accuracy
validation using QC samples as described in Section 3.3.5.2. QC samples were
determined in replicate (n = 6) at three different concentrations: 2, 50, and 100 nM.
Within the range of 2–100 nM, the intra-day and inter-day precisions (CV%) were
between 1.2 to 9.8% for each QC level of analytes. The accuracy (RE%), determined for
QC samples, was within -9.3 to 8.3% for each QC level of analytes.
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Analyte
(nM)
GroPIns
2
50
100
GroPCh
o
2
50
100
GroP
2
50
100
Inositol
2
50
100
Choline
2
50
100

Intra-day (n=6)

Inter-day (n=6)

Mean

SD

PRE
(CV%)

ACC
(RE%)

Mean

SD

PRE
(CV%)

ACC
(RE%)

2.04
48.37
92.66

0.12
1.46
2.27

5.88
3.02.
2.45

2.16
-3.26
-7.34

1.92
53.25
90.66

0.09
3.64
5.82

4.69
6.84
6.42

-4.64
6.52
-9.35

1.97
52.01
94.67

0.09
2.42
1.17

4.57
4.65
1.24

-1.58
4.02
-5.33

2.05
47.62
92.13

0.11
1.17
3.87

5.37
2.46
4.20

2.51
-4.76
-7.87

1.89
51.39
96.64

0.07
1.98
4.61

3.70
3.85
4.77

-5.53
2.78
-3.36

1.94
53.22
95.27

0.14
4.21
2.36

7.22
7.91
2.48

-3.68
6.44
-4.73

2.07
47.65
91.58

0.11
2.61
3.52

5.31
5.48
3.84

3.54
-4.77
-8.42

1.97
47.29
94.63

0.14
4.62
3.10

7.11
9.77
3.28

-3.74
-5.42
-5.37

1.92
54.11
94.28

0.06
1.29
4.17

3.13
2.38
4.42

-4.65
8.22-5.72

1.95
46.74
92.18

0.09
2.73
4.71

4.62
5.84
5.11

-2.52
-6.53
-7.82

Table 3-6 Intra- and inter-day precision and accuracy of the QC samples (n=6 in 3 runs). SD:
standard deviation. PRE: precision. ACC: accuracy. The coefficient of variation (CV%) =
[Standard deviation/mean concentration measured] × 100. The relative error (RE%) = [(mean
concentration measured-nominal concentration)/nominal concentration] × 100.

3.4.3.5 Matrix Effect

The absolute matrix effects, the ratio of the peak areas of three-concentration level
standards spiked in medium extracts to areas of the standards spiked in mobile phase (10
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mM ammonium acetate in acetonitrile/water, 70:30 (v/v)), were measured to be 95.6%,
97.7%, 98.4%, 95.3%, and 97.0% for GroPIns, GroPCho, GroP, inositol, and choline,
respectively (Table 3-7). The matrix effect value of <100% indicates ionization
suppression. The matrix was found to have negligible impact on the ionization, as the
variation in signal was less than 10% for all analytes. The absolute matrix effect value of
IS at 50 nM in the medium was observed to be 96.7%.

Analyte
GroPIns
GroPCho
GroP
Inositol
Choline

Absolute matrix effect (%)
LQC
97.2
97.4
98.5
94.2
98.6

MQC
94.3
95.9
97.6
96.6
95.1

HQC
95.3
99.8
99.0
95.1
97.3

Mean
95.6
97.7
98.4
95.3
97.0

Recovery (%)
LQC
72.5
70.5
81.7
82.9
73.6

MQC
75.1
72.9
78.4
83.3
77.9

HQC
75.6
74.4
82.0
81.3
76.2

Mean
74.4
72.6
80.7
82.5
75.9

Figure 3-7 Absolute matrix effect and recovery of all analytes at three concentrations of 2, 50 and
100 nM (n=6 in 3 runs). Absolute matrix effect expressed as the ratio of the mean peak areas of
three-concentration level standards spiked in medium extracts to those from standards spiked in
the mobile phase multiplied by 100. Recovery calculated as the ratio of the mean peak areas of
medium spiked with standards at three levels to those of blank medium extracts spiked with
standards at equivalent concentrations multiplied by 100.

3.4.3.6 Stability

The stability of QC samples at 2 and 100 nM were determined after the following
manipulations: three freeze/thaw cycles, 4-h storage at room temperature, 30-day storage
at -20°C, and autosampler reinjection after 24 h (Table 3-8). QC samples were stable in
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different storage conditions, as their assay values were within the acceptable limits of
accuracy (±15% RE) and precision (±15% CV).

Analyte

GroPIns

GroPCho

GroP

Inositol

Choline

LQC
Storage
Conditio
n
FT-3
Short-T
Long-T
Auto-R
FT-3
Short-T
Long-T
Auto-R
FT-3
Short-T
Long-T
Auto-R
FT-3
Short-T
Long-T
Auto-R
FT-3
Short-T
Long-T
Auto-R

Mean
(nM)
1.97
1.99
2.02
1.85
1.96
1.98
1.94
1.88
1.97
2.01
1.90
1.89
1.96
2.02
1.98
1.84
2.03
1.95
1.91
1.87

HQC

PRE
(CV%)

ACC
(RE%)

2.72
4.63
3.57
4.48
5.12
4.80
4.27
3.92
3.16
2.57
4.43
3.87
2.64
4.39
3.61
4.74
5.89
3.72
3.24
2.67

-1.54
-0.58
-1.45
-7.56
-2.81
-1.70
-3.35
-6.12
-0.15
0.54
-5.03
-5.56
-2.68
1.32
-1.60
-7.25
1.59
-2.52
-4.52
-6.58

Mean
(nM)
96.28
97.52
95.05
89.94
97.77
99.56
93.23
91.02
100.43
97.22
96.39
88.54
94.60
97.91
95.13
90.67
97.92
99.36
89.63
90.42

PRE
(CV%)

ACC
(RE%)

4.67
5.05
3.52
4.34
2.78
3.41
2.90
5.33
4.01
4.26
5.53
3.11
2.46
5.18
3.62
4.54
4.36
2.91
3.83
4.06

-3.85
-2.54
-5.62
-10.11
-2.36
-0.58
-6.84
-9.42
0.49
-2.84
-3.76
-11.52
-5.44
-2.16
-4.92
-9.47
-2.18
-0.72
-10.45
-9.64

Table 3-8 Stability of QC samples (n=6). FT-3: three freeze/thaw cycles. Short-T: 4-h storage at
room temperature. Long-T: 30-day storage at -20°C. Auto-R: autosampler reinjection after 24 h
at room temperature. The coefficient of variation (CV%) = [Standard deviation/mean
concentration measured] × 100. The relative error (RE%) = [(mean concentration measurednominal concentration)/nominal concentration] × 100.
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3.4.4 Application to a Biological Analysis

To apply the developed method to a biological system, we monitored the medium
of S. cerevisiae cultures containing wild type cells and cultures containing mutant strains
in which one or more of the phospholipase B genes had been deleted. We first monitored
the culture medium prior to the addition of cells in order to get a zero time reading
(Figure 3-13) and again after several hours, at which point the cells had reached the
stationary phase of growth (Figure 3-14).
Based on prior literature using radiolabeling, we expected to see a decrease in
GroPCho levels in strains lacking the PLB1 gene and a decrease in GroPIns levels in
strains lacking the PLB3 gene, but had no firm estimate of the absolute quantities of these
metabolites [20, 21, 46]. Since we supplemented the medium with inositol and choline,
we expected to see a decrease in those metabolites as a function of growth, but did dot
have an estimate of the extent of uptake by the cells. With regard to GroP, we did not
know if this compound would be detected extracellularly and had no expectation
regarding its extracellular concentration. As shown in Figure 3-13, the mean
concentrations of inositol and choline in blank medium were determined to be 61.8 μM
and 15.18 μM, which are in close agreement with the supplemented concentrations of
75μ M and 20 μM when the recovery values of 82.5% and 75.9% are taken into
consideration.
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Figure 3-13 Blank medium supplemented with 75 μM inositol, and 20 μM choline was analyzed
at time 0. Data represented as concentration (μM) as a function of cell growth (OD600). The error
bars represent the variation of three individual experiments. Values represent mean ± S.E. of
triplicate determinations.

As shown in Figure 3-14, the concentration of inositol decreased in all strains to
approximately 22-25 μM. Interestingly, the concentration of choline in the medium
decreased to a greater extent for the wild type strain than it did for any of the strains
bearing a mutated copy of a PLB gene. This finding suggests that either choline transport
is diminished in the mutant strains or that the production and subsequent release of
choline is exacerbated in the mutant strains. Further studies will be needed in order to
reconcile these possibilities.
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Figure 3-14 Determination of lipid-related extracellular metabolites of S. cerevisiae in wild cells
and in response to deletion of PLB1, PLB2, and PLB3 genes encoding for phospholipases B.
Strains grown in medium were harvested at stationary phase after approximately 24 hours of
growth for the PLB activity assays. Data represented as concentration (μM) as a function of cell
growth (OD600). The inset showed the mean concentrations of GroPIns and GroPCho in detail.
The error bars represent the variation of three individual experiments. Values represent mean ±
S.E. of triplicate determinations.

Also interesting is that not only is GroP detected in the medium, but that the level
is greater in the wild type strain than in any of the mutant strains. Again, further
experiments will be needed to understand the metabolic underpinnings of this result.
With regard to GroPCho levels, we observed the most severe decrease in levels in the
plb1Δ and plb1-3Δ mutant as compared to the wild type strain, as expected. Somewhat
surprising was that the plb2Δ and plb3Δ mutants also exhibited a decrease in GroPCho,
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whereas the published data using radiolabeling saw little or no decrease in that metabolite
in the plb2Δ and plb3Δ strains [20, 21, 46]. These differences may be due to the
limitations associated with radiolabeling with 14C-choline, since only the pool of choline
taken up by the cell is labeled and not that derived from de novo synthesis. Also, genetic
differences between the strain backgrounds and variations in the time of growth between
the experiments may account for these differences. With regard to GroPIns levels, we
did not see a decrease in the plb3Δ mutant strain, contrary to what we expected from the
literature [20, 21, 46]. Therefore, we performed another experiment using only a wild
type strain and a plb3Δ mutant (Figure 3-15) in which we monitored the level of
metabolites at an earlier point in their growth phase, the logarithmic phase of growth, as
careful examination of the published reports suggest that those studies were likely
performed with logarithmically growing cells. Under those conditions, we observed the
expected approximately 50% decrease in GroPIns levels in the plb3Δ mutant as
compared to wild type (Figure 3-15).
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Figure 3-15 Determination of lipid-related extracellular metabolites of S. cerevisiae in wild cells
and in response to deletion of PLB3 genes encoding for phospholipases B. Strains grown in
medium were harvested at log phase after 10-12 hours of growth for the PLB activity assays.
Data represented as concentration (μM) as a function of cell growth (OD600). The inset showed
the mean concentrations of GroPIns and GroPCho in detail. The error bars represent the
variation of three individual experiments. Values represent mean ± S.E. of triplicate
determinations.

To summarize the biological application of this newly developed methodology, we
were able to confirm the general trends expected for the extracellular levels of GroPIns
and GroPCho in wild type and mutant strains. However, much additional information
was obtained regarding the absolute levels of these metabolites and the levels of GroP,
inositol, and choline in the medium as a function of growth and the absence of particular
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PLB encoding genes. Thus, the application of this approach has opened up new avenues
of potential research.

3.5 Conclusions

We have successfully developed and validated an efficient analytical method based
on HILIC-MS/MS for the quantification of lipid-related extracellular metabolites in S.
cerevisiae. In comparison with traditional radiolabelling methods and other LC-MS/MS
methods, our approach is simple, robust, and well suited to metabolomic studies.
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Appendix 1

Comparison of On-chip Lipid Extraction Method Using
Different Eluents on Silica or C18 Stationary Phases to
Bligh and Dyer Extraction Method for Evaluating the
Extraction Efficiency of Microchip

A.1 Abstract

A library for comparing the identified phospholipids extracted from microchip using
different eluents: methanol, isopropanol or acetonitrile on silica stationary phase and 2:1
chloroform/methanol or 1:1 tetrahydrofuran/methanol on C18 stationary phase with the
total lipid species extracted by Bligh and Dyer method. From the results, the on-chip
extraction efficiency is achieved as the number of identified phospholipids species
obtained using the microchip method as compared to the modified Bligh-Dyer method.
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Silica Phase
m/z
985.7
983.7
979.6
973.6
969.6
963.5
959.6
957.6
955.6
953.6
945.6
935.7
931.6
929.6
923.8
921.5
905.7
901.5
899.5
898.6
898.5
894.7
892.6
890.6
882.6

Bligh and Dyer
Extraction
40:2 PIp/40:1
PIp
40:2 PIp/40:3
PIp
40:3 PIPp/40:4
PIPe
38:0 PIP/44:2 PI
38:2 PIP/44:4 PI
38:5 PIP
38:1 PIp/38:0
PIp
38:0 PIPp/38:1
PIPe
38:1 PIPp/38:2
PIPe
38:2 PIPp/38:3
PIPe
42:2 PI
42:0 PI/42:1 PI
36:0 Pip/36:1
PIp
42:2 PIp
42:5 Pip/42:6
PIe
42:6 PIp
40:1PI/40:2 PI
40:2 PIp/40:3
PIe
40:3 Pip/40:4
PIe
44:2 PC/44:3
PS/44:2 PS
40:5 PI/40:6 PI
44:4 PC/44:5
PS/44:3 PC
44:6 PS/44:5
PC/44:5 PS
44:6 PC/44:6 PS
43:4 PS/44:10
PC

MeOH

IPA

ACN

2:1
Chloroform
/MeOH

x

x

x

x

x
x
x
x

C18 Phase
1:1
Tetrahydrofuran
/MeOH

x
x

x
x
x

x

x

x

x

x

x

x

x

x

x

x

x

x
x
x

x
x

x

x

x

x
x

x

x
x

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
x

x

x

x

x

x
x
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x

Silica Phase
m/z
881.5
880.7
879.7
877.6
875.5
869.5
868.6
866.7
865.6
864.5
861.7
860.6
859.6
858.7
857.5
856.6
854.6
851.6
850.7
850.6
848.6
847.6
846.7
846.6
838.6

Bligh and Dyer
Extraction
38:6 PI
43:4 PC
38:1 PI/38:0 PI
38:0 Pip/38:1
PIe
32:0 PIp/32:1
PIp
38:5 PI/38:6 PI
42:3 PC/42:4
PS/42:3 PS
42:4 PC/42:5
PS/42:4 PS
37:0 PI/37:1 PI
42:5 PC/42:6
PS/42:5 PS
36:2 PI/42:0 PG
42:7 PC/41:0
PC/44:0 PE
42:2 PG/36:4 PI
42:0 PCp/42:1
PCe/44:1 PE
36:4 PI/42:2 PG
42:2 PSp 44:2
PE
42:10 PC/41:4
PS
36:0 PI/36:1 PI
44:5 PE/42:4
PCp /42:5 PCe
44:4 PE/42:5
PSe
42:6 Pce/40:0 PS
/44:6 PE
42:0 Pge/36:1
PIp /36:2 PIe
40:0 PC/40:1 PS
/42:6 PCp
42:6 PSp/40:0
PS /44:6 PE
40:5 PS/40:4 PC

MeOH
x
x
x

C18 Phase

x

1:1
Tetrahydrofuran
/MeOH
x
x
x

x

x

x

x

x

IPA

ACN

x
x

x
x
x

x

x

2:1
Chloroform
/MeOH
x

x
x
x

x

x

x
x

x

x

x
x

x

x
x

x

x

x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x

x
x

x

x

x

x

x

x

x

x

x
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x

x

x

x

x

x

x

Silica Phase
m/z
837.6
836.6
835.6
832.6
831.5
830.7
829.5
828.6
826.6
825.5
824.6
823.6
822.5
821.6
820.6
819.5
818.6
816.6
812.6
810.5
806.6
805.6
802.7

Bligh and Dyer
Extraction
35:0 PI/35:1 PI
40:5 PC/40:6
PS/40:5 PS
34:1 PI
39:1 PS/39:0
PC/42:0 PE
34:3 PI/40:1 PG
40:0 PCp/40:1
Pce/40:1 PSp
34:5 PI
40:2 PS/40:3 PS
40:3 PS/40:4
PS/39:4 PS
33:0 PI
39:4 PC/42:4
PE/40:4 PS
34:0 PI/34:1 PI
40:4 PCp/40:5
Pce/40:5 PSp
39:0 PG/34:1 PI
38:0 PS/40:5
PCp /40:6 PS
40:8 PG
38:0 PC/38:1 PS
/40:6 PCp
38:1 PC/38:2 PS
/42:0 PE/38:1 PS
/42:0 PEe
38:3 PC/38:4 PS
/42:2 Pep/38:3
PS /42:2 PEe
38:4 PC/38:5 PS
/42:4 Pee/38:4
PS/ 42:2 PEp
38:0 PSe/38:6
PC, 42:5 PEp
/42:6 PEe
38:0 PG
38:0 PCp, 38:1
PCp/38:1
PSp/40:1 PE

C18 Phase

x

2:1
Chloroform
/MeOH
x

1:1
Tetrahydrofuran
/MeOH
x

x

x

x

x

x

x

MeOH

IPA

ACN

x

x
x

x
x

x

x
x

x
x

x

x

x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
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x

x

x

Silica Phase
m/z
801.5
800.7
799.6
798.5
797.5
796.5
795.5
794.6
793.6
792.6
790.7
790.6
786.5
784.6
784.5
782.6
777.6
776.6
774.5
772.5
771.4
769.6
768.6
767.5

Bligh and Dyer
Extraction
32:5 PI
38:1 PCp/38:2
PCe/38:2
PSp/40:2 PE
43:2 PA
38:2 PCp/38:3
PCe/38:3
PSp/40:3 PE
31:0 PI
38:3 PCp/38:4
PCe/38:4
PSp/40:4 PE
32:0 Pie/38:5 PG
38:4 PC/38:5 PS
38:0 PG/32:1 PI
38:5 PC/38:6 PC
36:0 PC/36:1 PS
/40:0 PEe
37:0 PS
36:2 PC/36:3 PS,
40:1 Pep/40:2
PEe
36:3 PC/36:4 PS,
40:2 Pep/40:3
PEe
36:3 PS/40:1
PEp /40:2 PEe
36:4 PC/40:4
PEe
36:1 PG
36:0 PCe/38:0
PE /40:6 PEp
35:2 PS/36:2 PS
35:3 PS
30:5 PI/36:3 PG
41:3 PA/29:0 PI
38:4 PE/36:3
PCp /36:4
PCe/38:3 PE
30:0 PIe

MeOH

IPA

C18 Phase
ACN

x
x

x

2:1
Chloroform
/MeOH
x

x

1:1
Tetrahydrofuran
/MeOH

x

x
x

x

x

x
x

x

x

x

x
x
x

x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x
x
x
x

x

x

x

x

x

x

x

x
x
x

x

x

x
x
x
x

x
x
x
x

x

x

x

x

x

x
x

x
x
x

130

x

Silica Phase
m/z
766.6
765.5
764.6
761.6
760.6
758.6
757.5
754.5
753.5
752.6
751.6
751.3
750.6
749.4
746.6
745.6
742.6
741.5
740.5
739.4
738.4
737.5
736.5
735.5

Bligh and Dyer
Extraction
36:4 PCp/38:5
PE/38:4 PE
30:0 Pip/30:1
PIe
34:0 PS/35:0 PS
36:1 PG/36:2 PG
34:1 PC/38:0
PEp /38:1
Pee/38:0 PEe
34:2 PC/38:0
PEp /38:1 PEe
36:2 PGp/36:3
PGe
34:4 PC/38:3
PEp /38:4
Pee/38:2
Pep/38:3 PEe
28:0 PI/36:4
PGp /36:5 PGe
38:3 Pep/38:4
Pe/34:5 PC/38:4
Pep/38:5 PEe
35:0 PG/40:5 PA
22:0 PIp
33:0 PS/34:0 PS
28:2 PI/34:0 PG
34:0 PC/34:1
PC/37:0 PE
40:0 PA/ 40:1
PA/40:8 PA
34:2 PCp/34:3
PCe/36:3 PE
34:5 PG
33:4 PC/36:4 PE
34:6 PG
36:4
PE/34:4/36:5 PE
34:6 PG
36:5 PE/32:0
PS/33:0 PSe
34:0 PGe

MeOH

IPA

C18 Phase
ACN

x
x

2:1
Chloroform
/MeOH

1:1
Tetrahydrofuran
/MeOH

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
x
x

x

x

x

x

x

x
x

x
x
x
x

x
x
x
x

x

x

x

x

x

x

x

x

x
x
x

x
x

x
x

x

x

x

x
x
x
x

x

x

x

x

x

x

x

x

x

x

x

x

x
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x

x

x

Silica Phase
m/z
734.5
733.5
732.6
730.4
729.4
728.5
725.4
724.5
723.6
718.5
716.6
714.4
711.4
708.4
707.5
706.6
704.6
703.6
702.5
701.5
698.4
697.3
694.5
692.6
690.5
688.5

Bligh and Dyer
Extraction
33:0 PS/32:0
PS/36:0 PEe
34:0 PGp/34:1
PGe
32:1 PC/36:0
PEp /36:1 PEe
32:2PC/35:2
PE/36:0
Pep/36:1 PEe
33:4 PG
32:3 PS/36:1
PEp
26:1 PI
32:6 PS/32:5
PC/36:5 PE/36:3
Pep36:4 PEe
33:0 PG/38:5 PA
32:1 PC/32:0
PC/35:0 PE/34:0
PE
32:1 PC/35:1 PE
34:3 PE/31:3 PC
32:6 PG/38:3 PA
34:6 PE/31:0 PS
32:0 PGe/38:4
Pap/38:5 PAe
31:0 PC/34:0 PE
34:0PE/34:1 PE
37:0 PA/37:1 PA
30:2 PC/33:2 PE
36:1 PA
30:5 PS/34:3 PE
24:1 PI/36:4 PA
29:0 PS/30:0 PS
30:0 PCe/30:0
PS /32:0 PE
30:0 PC/30:1
PCe /32:1 PE
32:2 PE/30:1
PCp

C18 Phase

MeOH

IPA

ACN

2:1
Chloroform
/MeOH

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
x

x
x

x

x

x

x

x

x

x
x
x
x

x
x
x
x
x
x
x

x
x
x
x
x
x
x
x

x

x

x

x

x

x

x

x

x

x
x

x

x

x

x

x

x

x
x
x

x

x

x
x

x

x

x

x

x

132

1:1
Tetrahydrofuran
/MeOH

Silica Phase
m/z
686.5
683.4
680.4
679.5
678.5
677.5
676.5
676.4
675.4
674.5
673.4
673.4
672.4
671.5
667.4
664.5
663.6
662.6
660.5
655.5
654.4
653.5
651.4
650.4
649.2
647.3
643.3
639.4

Bligh and Dyer
Extraction
32:3 PE
36:2 Pap/36:3
PAe
32:6 PE/28:0 PS
30:0 PGe/36:4
PAp
28:0 PS/32:6
PE28:0/PC, 28:1
PS/32:0 PEe
34:0 PA
28:0 PC/28:1 PS
/32:0 PEe
29:2 PG/28:2 PS
18:3 Pip/34:0 PA
28:2 PC/31:2 PE
35:2 PA/35:1
PA/34:1 PA
34:2 PA
31:3 PE/28::3
PC
34:2 PA
18:0 PIp/34:5
PA
28:0 PC/30:0 PE
34:0 PA/33:0 PA
28:0 PC/30:1 PE
28:0 PCp/30:1
PE/30:2 PE
22:0 LPI/34:2
Pap/34:3 PAe
30:5 PE/30:4 PE
28:0 PG/33:5 PA
16:0 LPIP/22:2
LPI/28:0 PGe
26:1 PS/26:0 PC
16:1 LPIP
22:4 LPI/32:0
PA
20:0 PI/21:0 PI
32:4 PA

C18 Phase

MeOH

IPA

ACN

x

x

x

x

2:1
Chloroform
/MeOH
x

1:1
Tetrahydrofuran
/MeOH
x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x

x

x
x
x

x
x
x

x

x

x

x

x

x

x

x

x

x

x
x
x

x
x
x

x

x

x

x

x

x

x
x

x
x

x
x

x

x

x

x

x
x

x
x

x
x

x

x

x

x

x
x

x
x

x
x

x
x

x
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x

x

Silica Phase
m/z
638.4
636.5
634.5
633.5
627.4
623.4
622.5
620.4
618.4
611.4
608.3
603.5
597.3
594.4
589.4
585.4
583.3
581.3
580.4
570.4
569.4
568.3
566.3
559.3

Bligh and Dyer
Extraction
26:1 PG/26:0 PS
26:0 PS/29:0 PE
26:0 PCe/28:0
PE/26:0 PCp/
28:1 PE
32:0 PA/32:1
PA/31:1 PA
20:0 LPI/31:3
PA
26:0 PG
24:0 PC/28:0
PEe
24:1 PC/8:0 PEp
24:1 PC/28:0
PEp
30:5 PA/20:0
LPI/30:4 PA
23:0 PC/26:0 PE
30:1 PA/30:0 PA
23:0 PG/18:1
LPI
22:0 PC/25:0 PE
28:2 PA
18:0 PI/17:1
PI/28:3 PA
22:0 PG/18:0
LPI
22:0 PS/22:0 PG
24:0 PE/22:0 PC
22:6 PS/22:5
LPC
22:0 LPG/16:1
LPI
20:0 LPS/21:0
LPS/22:6
LPS/22:6 LPC
20:0
LPC/23:0/21:0
LPS LPE
15:0 LPI/16:0
LPI

C18 Phase
2:1
Chloroform
/MeOH
x
x

1:1
Tetrahydrofuran
/MeOH
x
x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x
x

x
x

x

x

x

x

x
x

x
x

x

x

x

MeOH

IPA

ACN

x

x

x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x
x

x

x

x

x

x

x

x

x

x

x

x

x
x
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Silica Phase
m/z
555.3
552.6
550.4
544.5
543.3
537.3
536.3
535.4
532.3
524.3
523.3
522.4
518.3
510.3
508.3
506.3
500.3
497.3
496.6
495.4
494.2
481.4
480.4
478.3

Bligh and Dyer
Extraction
16:0 LPI/21:0
LPG
20:1 LPS/22:0
LPE/20:0 LPC
20:2 LPS/20:1
LPS
20:4 LPC
14:1 LPI
20:2 LPG/24:0
LPA
22:1 LPE/20:0
LPC
24:1 LPA/20:3
LPG
13:0 LPI/22:2
LPE
18:1 LPS/20:0
LPE
23:0 LPA
18:1 LPC/18:0
LPC
18:3 LPC/18:2
LPC
17:1 LPS/18:0
LPS
18:0 LPC/17:1
LPC
17:2 LPC/20:2
LPE/20:1 LPE
20:5 LPE
18:0 LPG/17:1
LPG
16:1 LPS/20:0
LPE/16:0 LPC
22:0 LPA
20:0 LPE/16:1
LPS/16:1 LPC
21:0 LPA/20:0
LPA
16:0 LPC
18:2 LPE

MeOH

IPA

C18 Phase
ACN

2:1
Chloroform
/MeOH

1:1
Tetrahydrofuran
/MeOH

x
x
x

x

x

x

x

x
x
x
x

x

x
x

x

x
x
x

x

x

x

x

x

x

x

x

x

x

x

x

x
x

x

x

x
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x

Silica Phase
m/z
468.5
467.3
466.3
465.4
464.2
456.3
455.2
453.4
442.3
440.5
425.3
412.3
353.2
327.2

Bligh and Dyer
Extraction
18:0 LPE/17:0
LPE
20:0 LPA
14:1 LPC/17:1
LPE/18:0 LPE
20:1 LPA
17:2 LPE
13:0 LPS
13:0 LPC/16:0
LPE/14:0 LPG
20:0 LPA/19:0
LPA
12:0 LPS
16:0 LPE
17:0 LPA/18:0
LPA
10:0 LPC/13:0
LPE
12:0 LPA
10:0 LPA

MeOH

IPA

x

C18 Phase
ACN

2:1
Chloroform
/MeOH

1:1
Tetrahydrofuran
/MeOH

x

x

x

x

x

x
x

x

Table A-1 Library of Identified glycerophospholipd species eluted by different eluents on silica or
C18 stationary phases compared to total lipid species by Bligh and Dyer method for evaluation of
on-chip extraction efficiency. The matched glycerophospholipid species are marked by “x” within
a mass error window of 10 ppm. Phospholipids are presented with a class abbreviation preceded
by xx:y, where xx is the total fatty acid carbon number and y is the number of double bonds. The
following abbreviations are used: PA, phosphatidic acid; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS,
phosphatidylserine; LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; LPE,
lysophosphatidylethanolamine; LPG, lysophosphatidylglycerol; LPI, lysophosphatidylinositol; LPS,
lysophosphatidylserine; PIP, phosphatidylinositol phosphate. PC, PE, PI and PIP with a lower
case e and/or p refer to plasmanyl and plasmenyl (alkyl ether and plasmalogens) subspecies,
respectively.
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Appendix 2

Library of Identified Phospholipid Species in
Sulfurospirillum barnesii Cells Extracted from the
Microchip

A.2 Abstract

A library for identified glycerophospholipids extracted from Sulfurospirillum
barnesii strain SES-3 cells based on the matches of METLIN Personal Metabolite
database and LIPID MAPS database was established. The glycerophospholipids were
extracted by using methanol as the eluent on microchip packed with silica stationary
phase.
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Measured
mass
353.177
431.219
440.492
455.245
468.507
494.250
494.227
496.643
500.381
506.322
506.320
518.360
518.329
522.350
522.360
532.345
544.542
550.313
550.382
552.605
566.350
568.271
568.337
569.350
570.360
581.351
583.322
585.361
589.384
597.301
603.454
608.331
611.363
618.419
620.633
622.492
627.397
634.475

Theoretical
mass
353.173
431.220
440.494
455.242
468.505
494.252
494.224
496.640
500.377
506.325
506.324
518.359
518.324
522.353
522.355
532.341
544.540
550.315
550.386
552.602
566.346
568.268
568.334
569.353
570.356
581.346
583.325
585.356
589.388
597.305
603.450
608.329
611.357 a/o
611.369
618.414 a/o
618.420
620.629 a/o
620.635
622.494 a/o
622.489
627.392 a/o
627.402
634.480 a/o
634.470

Error
(ppm)
9.6
-2.8
-4.5
8.3
5.3
-5.3
6.5
5.4
8.4
-7.5
-8.9
1.9
8.8
-5.6
9.6
8.5
3.7
-4.4
-7.3
5.4
7.2
4.9
5.3
-5.1
7.0
8.9
-6.2
8.4
-5.4
8.7
7.5
3.3
9.9 a/o 9.9
7.8 a/o 2.6
6.4 a/o 3.2
-3.2 a/o
4.8
8.1 a/o 7.7
-8.0 a/o
7.6

Negative
12:0 LPA
18:3 LPA

Ionization mode
Positive
16:0 LPE

14:0 LPG
18:0 LPE
16:1 LPS
16:1 LPC
16:0 LPC
20:5 LPE
20:1 LPE
20:2 LPE
18:2 LPC
18:3 LPC
18:0 LPC
18:1 LPC
22:2 LPE
20:4 LPC
20:1 LPS
20:1 LPC
20:0 LPC
21:0 LPS
22:6 LPS
22:6 LPC
16:1 LPI
22:5 LPC
22:0 PG
18:0 LPI
28:3 PA
28:1 PA
18:1 LPI
30:0 PA
26:0 PE
20:0 LPI a/o 30:4 PA
24:1 PC a/o 28:0 PEp
24:1 PC a/o 28:0 PEp
24:0 PC a/o 28:0 PEe
20:0 LPI a/o 31:3 PA
26:0 PCe a/o 28:0 PE
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Measured
mass
634.486
638.446
639.407
647.315
649.246
651.357
654.416
654.418
655.479
660.494
660.457
662.616
664.527
671.538
673.376
675.399
676.501
676.497
678.429
678.511
679.487
683.606
686.478
688.501

Theoretical
mass
634.481 a/o
634.490
638.439
639.403
647.320 a/o
647.310
649.240
651.355,
651.352 a/o
651.361
654.414
654.413
655.483,
655.476 a/o
655.476
660.497 a/o
660.489
660.460
662.612 a/o
662.622
664.528 a/o
664.531
671.536
673.381
675.397
676.497,
676.504 a/o
676.504
676.491,
676.502 a/o
676.502
678.435 a/o
678.424
678.507,
678.514 a/o
678.513
679.492 a/o
679.481
683.602 a/o
683.602
686.476
688.495 a/o
688.508

Error
(ppm)
7.9 a/o 6.3
10.0
5.9
-8.8 a/o
7.4
9.2
3.0, 7.7
a/o -6.1

Negative

Ionization mode
Positive
26:0 PCp a/o 28:1 PE
26:0 PS

32:4 PA
22:4 LPI a/o 32:0 PA
16:1 LPIP
16:0 LPIP, 22:2 LPI
a/o 28:0 PGe

3.1
7.6
-6.1, 4.6
a/o 4.6

30:4 PE

-4.5 a/o
7.6
-4.5
6.0 a/o 9.1
-1.5 a/o 6.0
3.0
-7.4
2.9
5.9, -4.4
a/o -4.4

28:0 PCp a/o 30:1 PE

30:5 PE
22:0 LPI, 34:2 PAp a/o
34:3 PAe

30:2 PE
28:0 PC a/o 30:1 PE
28:0 PC a/o 30:0 PE
34:2 PA
34:1 PA
34:0 PA
28:0 PC, 28:1 PS a/o
32:0 PEe

8.9, -7.4
a/o -7.4

28:1 PC, 32:0 PEp
a/o 32:1 PEe

-8.7 a/o
7.4
5.9, -4.4
a/o -2.9

28:0 PS a/o 32:6 PE

-7.4 a/o
8.8
5.9 a/o
5.9
2.9
8.7 a/o 10.0

30:0 PGe a/o 36:4 PAp

28:0 PC, 28:1 PS a/o
32:0 PEe

36:2 PAp a/o 36:3 PAe
32:3 PE
32:2 PE a/o 30:1 PCp
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Measured
mass
690.549
692.564
701.509
707.519
714.398
718.602
718.500
724.530
724.520
728.457
728.556
730.474
730.440
732.583
733.442
734.504
734.572
735.461
736.499
736.507
737.543
738.402

Theoretical
mass
690.543,
690.543 a/o
690.552
692.559,
692.566 a/o
692.563
701.513
707.523,
707.512 a/o
707.512
714.394
718.599
718.495,
718.495 a/o
718.498
724.529 a/o
724.529
724.525,
724.518 a/o
724.518
728.451 a/o
728.460
728.553
728.559 a/o
728.559
730.476 a/o
730.476
730.438,
730.445 a/o
730.445
732.576,
732.590 a/o
732.590
733.439 a/o
733.439
734.498
734.570 a/o
734.569
735.455
736.492
736.512 a/o
736.509
737.540
738.408

Error
(ppm)
8.7, 8.7
a/o -4.3

Negative

Ionization mode
Positive
30:0 PC, 30:1 PCe
a/o 32:1 PE

7.2, -2.9
a/o 1.4
-5.7
-6.0, 9.9
a/o 9.9
5.6
4.2
9.7, 9.7
a/o 5.6

30:0 PCe, 30:0 PS
a/o 32:0 PE
36:1 PA
32:0 PGe, 38:4 PAp
a/o 38:5 PAe
34:3 PE
34:0 PE
32:0 PCp, 32:1 PCe
a/o 34:1 PE

1.3 a/o
1.3
-4.1, 5.5
a/o 5.5

36:3 Pep a/o 36:4 PEe

8.2 a/o
4.4
4.3, -4.0
a/o -4.0

32:3 PS a/o 36:1 PEp

-2.7 a/o 2.7
2.7, -6.8
a/o -6.8

36:0 PEp a/o 36:1 PEe

32:5 PC, 36:4 PEp
a/o 36:5 PEe

32:3 PC, 36:2 PEp
a/o 36:3 PEe

32:2 PC, 36:1 PEp
a/o 36:2 PEe

9.6, -8.8
a/o -8.8
4.1 a/o
4.1
4.1
2.7 a/o
4.1
8.2
9.5
-6.7 a/o 2.7
4.1
-8.1

32:1 PC, 36:0 PEp
a/o 36:1 PEe
34:0 PGp a/o 34:1 PGe
32:0 PS
32:0 PC a/o 36:0 PEe
34:0 PGe
36:5 PE
32:0 PS a/o 33:0 PSe
34:6 PG
36:4 PE
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Measured
mass
738.435
742.583
749.429
752.566
752.565
753.509
754.571
754.544
757.542
758.711
758.561
760.728
760.627
765.498
766.546
766.463
767.512
768.550
768.449
771.414
776.565

Theoretical
mass
738.430 a/o
738.437
742.575,
742.575 a/o
742.588
749.425 a/o
749.434
752.560 a/o
752.560
752.563,
752.559 a/o
752.559
753.516,
753.508 a/o
753.508
754.576 a/o
754.576
754.538,
754.545 a/o
754.545
757.539 a/o
757.539
758.707 a/o
758.707
758.568
760.723
760.631,
760.622 a/o
760.622
765.492 a/o
765.492
766.539
766.465 a/o
766.458
767.508
768.555
768.454,
768.446 a/o
768.446
771.409 a/o
771.418
776.558,
776,560 a/o
776.560

Error
(ppm)
6.8 a/o 3.3
10.0, 10.0
a/o -6.7

Negative

Ionization mode
Positive
34:4 a/o 36:5 PE
34:2 PCp, 34:3 PCe
a/o 36:3 PE

5.3 a/o 6.7
7.9 a/o
7.9
2.7, 8.0
a/o 8.0

28:2 PI a/o 34:0 PG

-9.3, 1.3
a/o 1.3

28:0 PI, 36:4 PGp a/o
36:5 PGe

-6.6 a/o 6.6
7.9, -1.3
a/o -1.3

38:2 PEp a/o 38:3 PEe

4.0 a/o
4.0
5.3 a/o
5.3
-9.2
6.6
-5.3, 6.6
a/o 6.6

36:2 PGp a/o 36:3 PGe

7.8 a/o
7.8
9.1
-2.6 a/o
6.5
5.2
-6.5
-6.5, 3.9
a/o 3.9

30:0 PIp a/o 30:1 PIe

6.5 a/o 5.2
9.0, 6.4
a/o 6.4

30:5 PI a/o 36:3 PG

38:3 PEp a/o 38:4 PEe
34:5 PC, 38:4 PEp
a/o 38:5 PEe

34:4 PC, 38:3 PEp
a/o 38:4 PEe

38:0 PEp a/o 38:1 PEe
34:2 PC
38:0 PEe
34:1 PC, 38:0 PEp
a/o 38:1 PEe

38:4 PE
36:4 PCp a/o 38:5 PE
30:0 PIe
38:3 PE
38:4 PE, 36:3 PCp
a/o 36:4 PCe

36:0 PSe, 40:5 PEp a/o
40:6 PEe

141

Measured
mass
776.562
782.579
784.616
784.623

786.546

790.667
795.543
796.557

798.539

800.659

802.670

805.637
806.566

810.537

Theoretical
mass
776.563,
776.556 a/o
776.559
782.573 a/o
782.586
784.613,
784.623 a/o
784.623
784.628,
784.617,
784.622 a/o
784.622
786.541,
786.548,
786.540 a/o
786.540
790.662,
790.659 a/o
790.668
795.539 a/o
795.548
796.552,
796.552,
796.549 a/o
796.555
798.537,
798.537,
798.544 a/o
798.541
800.653,
800.653,
800.652 a/o
800.666
802.668,
802.668,
802.676 a/o
802.672
805.633
806.559,
806.570,
806.569 a/o
806.569
810.529 a/o
810.538

Error
(ppm)
-1.3, 7.7
a/o 3.9
7.7 a/o 8.9
3.8, -8.9
a/o -8.9

Negative

Ionization mode
Positive
36:0 PCe, 38:0 PE
a/o 40:6 PEp
36:4 PC a/o 40:4 PEe

36:3 PS, 40:1 PEp a/o
40:2 PEe

-6.4, 7.6,
1.3 a/o
1.3

36:3 PC, 36:4 PS,
40:2 PEp a/o 40:3
PEe

6.4, -2.5, 5.1 a/o 5.1

36:2 PC, 36:3 PS,
40:1 PEp a/o 40:2
PEe

6.3, 10.0
a/o -1.3

36:0 PC, 36:1 PS a/o
40:0 PEe

5.0 a/o 6.3
6.3, 6.3,
10.0 a/o
2.5

32:0 PIe a/o 38:5 PG
38:3 PCp, 38:4 PCe,
38:4 PSp a/o 40:4 PE

2.5, 2.5, 6.3 a/o 2.5

38:2 PCp, 38:3 PCe,
38:3 PSp a/o 40:3 PE

7.5, 7.5,
8.7 a/o 8.7

38:1 PCp, 38:2 PCe,
38:2 PSp a/o 40:2 PE

2.5, 2.5, 7.5 a/o 2.5

38:0 PCp, 38:1 PCp,
38:1 PSp a/o 40:1 PE

5.0
38:0 PG
8.7, -5.0, 3.7 a/o 3.7
9.9 a/o 1.2

38:4 PS a/o 42:2 PEp
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38:0 PSe, 38:6 PC,
42:5 PEp a/o 42:6
PEe

Measured
mass
810.533
812.478
812.657
816.579
816.581
818.605
820.598
822.539
830.631
830.696
831.507
835.585
836.552
836.660
846.701
846.629
847.577

Theoretical
mass
810.531,
810.528 a/o
810.537
812.473 a/o
812.482
812.661,
812.649 a/o
812.653
816.576 a/o
816.585
816.584,
816.575 a/o
816.584
818.603,
818.597 a/o
818.606
820.606,
820.602 a/o
820.595
822.537,
822.544 a/o
822.541
830.628 a/o
830.628 a/o
830.634
830.700,
830.700 a/o
830.693
831.503 a/o
831.512
835.584
836.545
836.657 a/o
836.654
846.696,
846.703 a/o
846.705
846.625,
846.622 a/o
846.637
847.580,
847.571 a/o
847.571

Error
(ppm)
2.5, 6.2
a/o -4.9

Negative

Ionization mode
Positive
38:4 PC, 38:5 PS a/o
42:4 PEe

6.2 a/o 4.9
-4.9, 9.8
a/o 4.9

38:3 PS a/o 42:2 PEe

3.7 a/o 7.3
-3.7, 7.3
a/o -3.7

38:1 PS a/o 42:0 PEe

38:3 PC, 38:4 PS a/o
42:2 PEp

38:1 PC, 38:2 PS a/o
42:0 PE

2.4, 9.8
a/o -1.2

38:0 PC, 38:1 PS a/o
40:6 PCp

-9.7, -4.9
a/o 3.7

38:0 PS, 40:5 PCp
a/o 40:6 PS

2.4, -6.1
a/o -2.4

40:4 PCp, 40:5 Pce
a/o 40:5 PSp

3.6, 3.6
a/o -3.6

40:0 PSp, 40:1 Pse a/o
42:0 PE

-4.8, -4.8
a/o 3.6
4.8 a/o 6.0
1.2
8.4
3.6 a/o
7.2
5.9, -2.4
a/o -4.7

40:0 PCp, 40:1 Pce
a/o 40:1 PSp
34:3 PI a/o 40:1 PG
34:1 PI
40:5 PS
40:5 PC a/o 40:6 PS
42:6 PSp, 40:0 PS a/o
44:6 PE

4.7, 8.3
a/o -9.4
-3.5, 7.1
a/o 7.1

40:0 PC, 40:1 PS a/o
42:6 PCp
42:0 Pge, 36:1 PIp a/o
36:2 PIe
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Measured
mass
848.601
848.640
850.595
850.677
856.650
857.509
858.703
861.653
864.555
864.541
866.700
866.669
868.611
868.603
877.613
880.682
881.482
890.638
890.670
892.602
892.610
894.702
894.697
898.503
898.629

Theoretical
mass
848.595 a/o
848.608
848.633,
848.638 a/o
848.646
850.603 a/o
850.597
850.672,
850.668 a/o
850.668
856.643 a/o
856.659
857.505 a/o
857.512
858.701,
858.701 a/o
858.697
861.650 a/o
861.659
864.557
864.545 a/o
864.548
866.692
866.663 a/o
866.671
868.607
868.599 a/o
868.606
877.618 a/o
877.618
880.679
881.477
890.632
890.663
892.607

Error
(ppm)
7.1 a/o 8.2
8.3 2.4
a/o -7.1

Ionization mode
Negative
Positive
42:5 PS a/o 44:5 PE

-9.4 a/o 2.4
5.9, 10
a/o 10.0

44:4 PE a/o 42:5 PSe

892.606 a/o
892.619
894.696
894.695 a/o
894.702
898.509
898.626 a/o
898.633

4.5 a/o 10.0
6.7
2.2 a/o 5.6
-7.8
3.3 a/o 4.5

8.2 a/o 10.0
5.8 a/o 4.7
2.3, 2.3
a/o 7.0
3.5 a/o 7.0
-3.5
-4.6 a/o 8.1
9.2
6.9 a/o 2.3
4.6
4.6 a/o 3.5
-5.7 a/o 5.7
3.4
6.8
7.9
4.2
-5.6

42:6 Pce, 40:0 PS a/o
44:6 PE

44:5 PE, 42:4 PCp
a/o 42:5 PCe
42:2 PSp a/o 44:2 PE
36:4 PI a/o 42:2 PG
42:0 PCp, 42:1 PCe
a/o 44:1 PE
36:2 PI a/o 42:0 PG
42:5 PS
42:5 PC a/o 42:6 PS
42:4 PS
42:4 PC a/o 42:5 PS
42:3 PS
42:3 PC a/o 42:4 PS
38:0 PIp a/o 38:1 PIe
43:4 PC
38:6 PI
44:6 PS
44:6 PC
44:5 PS
44:6 PS a/o 44:5 PC
44:3 PC
44:4 PC a/o 44:5 PS
44:2 PS
44:2 PC a/o 44:3 PS
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Measured
mass
899.497
901.514
921.483
923.607
929.657
945.650
953.562
955.571
957.589
963.508
969.638
973.584
979.570

Theoretical
mass
899.502 a/o
899.502
901.518 a/o
901.518
921.486
923.602 a/o
923.602
929.649
945.644
953.553 a/o
953.553
955.568 a/o
955.568
957.584 a/o
957.584
963.501
969.633 a/o
969.644
973.579 a/o
973.575
979.568 a/o
979.568

Error
(ppm)
-5.6 a/o 5.6
-4.4 a/o 4.4
-3.3
5.4 a/o
5.4
8.6
6.3
9.4 a/o
9.4
3.1 a/o
3.1
5.2 a/o
5.2
7.3
5.2 a/o 6.2
5.1 a/o
9.2
2.0 a/o
2.0

Ionization mode
Negative
Positive
40:3 PIp a/o 40:4 PIe
40:2 PIp a/o 40:3 PIe
42:6 PIp
42:5 PIp a/o 42:6 PIe
42:2 PIp
42:2 PI
38:2 PIPp a/o 38:3
PIPe
38:1 PIPp a/o 38:2
PIPe
38:0 PIPp a/o 38:1
PIPe
38:5 PIP
38:2 PIP a/o 44:4 PI
38:0 PIP a/o 44:2 PI
40:3 PIPp a/o 40:4
PIPe

Table A-2 Library of identified phospholipid species extracted from cells by microchip.
Phospholipids are presented with a class abbreviation preceded by xx:y, where xx is the total
fatty acid carbon number and y is the number of double bonds. The following abbreviations are
used: PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG,
phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; LPA, lysophosphatidic
acid; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPG,
lysophosphatidylglycerol; LPI, lysophosphatidylinositol; LPS, lysophosphatidylserine; PIP,
phosphatidylinositol phosphate. PC, PE, PI and PIP with a lower case e and/or p refer to
plasmanyl and plasmenyl (alkyl ether and plasmalogens) subspecies, respectively.
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